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Abstract 
 
Heat shock factor 1 (Hsf1) is a protein known to be involved in both stress and 
developmental processes through the regulation of heat shock proteins. However, to date, 
no studies have been performed on examining its expression in the myometrium during 
pregnancy. During pregnancy, the uterus undergoes many structural and functional 
changes, and it also endures both mechanical and hormonal stresses. Therefore, the 
purpose of this thesis was to characterize the expression of Hsf1, and its associated 
factors in the uterus during pregnancy. 
Immunoblot analysis determined that Hsf1 protein expression was high early in 
gestation (day (d) 6) and then decreased significantly from mid gestation onwards 
(specifically when compared to d15, d17 and d22, p<0.05, n=5). Immunofluorescence 
analysis, demonstrated that Hsf1 was readily detectable in the myometrium but did not 
markedly change over gestation. Hsf1 was also localized mainly in the cytoplasm of 
myometrial cells, with some granular staining in the nucleus. Many related proteins of 
Hsf1 were also detectable in the myometrium, during pregnancy, such as PARP-1 and 
Hsf2. These results indicate that Hsf1 could play an important role early in gestation 
either to aid in myometrial cell proliferation or to upregulate expression of key genes 
necessary for subsequent myometrial differentiation.    
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Chapter One 
Introduction 
1.1 Preterm Birth 
Preterm birth is the most common cause of perinatal mortality and morbidity in 
the developed world and is characterized as any infant born before the full 37 weeks of 
human gestation (Lumley 1993). In Canada, approximately 75-85% of all infant deaths, 
excluding babies with congenital defects, are a direct result of preterm birth (Shynlova et 
al., 2009). In 2005, it was estimated that 9.6% of births worldwide (or 12.9 million 
births) were preterm, with the majority of these births (11.9 million or 92.3%) occurring 
in Africa, Asia, Latin America, and the Caribbean (Beck et al., 2010). Preterm babies 
with weights lower than 2500 g occur in 10% of the total babies born every year. As 
these babies have a higher risk of long-term health defects, preterm birth has become a 
problem of huge clinical importance (Garfield & Maner, 2007). Furthermore, in the past 
20 to 30 years the incidence of preterm birth has not decreased, and is actually higher in 
certain population groups including within Canada (Challis 2001). This increase is most 
prominently observed in more high-income countries as the rate of medically indicated 
preterm babies in singleton births increases along with the number of pregnancies that 
are conceived with assisted reproductive technologies (Goldenberg et al., 2008). 
Preterm birth is often associated with a variety of long-term health defects such as 
cerebral palsy, blindness, deafness, respiratory illness and complications resulting from 
their stay in intensive care (Hack & Fanaroff, 1999; Ward & Beachy, 2003). 
Approximately 30% of preterm births occur as a result of an underlying infectious 
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process, while 50% are of unknown origin (Challis, 2001).  There are also several 
established risk factors for preterm labour such as previous low birth weight or preterm 
delivery, placental anomalies, cervical and uterine anomalies, gestational bleeding, in 
vitro fertilization pregnancy, infection, and cigarette smoking (Creasy et al., 1980; 
Goldenberg et al., 1996). There is also a substantial cost in simply caring for preterm 
babies. In Canada, the direct medical costs of the initial hospital stay for preterm births 
is approximately $20 million per year (Lasiuk et al., 2013).  
As of now, there is no treatment to prevent preterm labour, which is one of the 
underlying reasons for the high mortality rate associated with the condition (Garfield & 
Maner, 2007). Therefore, the main goal of research in this field is to gain a better 
understanding of the normal process of myometrial differentiation during pregnancy, 
including how the uterus becomes a highly contractile tissue.  This information is critical 
if better methods to detect, diagnose, and prevent preterm labour are going to be 
developed.  
 
1.2 The Myometrium: An Overview 
The uterus is a hollow organ, found only in females, and is located within the 
pelvis. It is composed of three distinct layers: a well-differentiated lining 
(endometrium), a thick muscular wall (myometrium) and a serosal outer layer (Aguilar 
& Mitchell, 2010). Throughout the course of pregnancy, the uterus undergoes major 
physiological adaptations to accommodate the developing fetus, placenta and amniotic 
fluid (Shynlova et al., 2007). As a result, the non-pregnant uterus has a volume of 
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approximately 10 mL, whereas, at term, the uterus has a volume of approximately 5L 
(Monga & Sanborn, 1995). The uterus as a whole serves two major functions during 
pregnancy: 1) to harbour the fetus and placenta in a safe and calm environment and 2) to 
coordinate the smooth muscle contractions at both the appropriate time and strength 
necessary to expel the fetus into the extra-uterine environment (Hertelendy & Zakar, 
2004). In the latter case, the contractions are mediated by the smooth muscle component 
of the uterus termed the myometrium.  
Smooth muscle is incredibly adaptable to changes in its environment and can 
accommodate the large amount of stimuli that act upon it (Taggart & Morgan, 2007). 
Therefore the myometrium, composed solely of smooth muscle, is vital in aiding several 
processes involved in reproduction, such as sperm and embryo transport, implantation 
and most notably, parturition (Aguilar & Mitchell, 2010). 
The rat myometrium has two very distinct muscle layers, the longitudinal muscle 
layer and the circular muscle layer, neither of which are distinctly recognizable in the 
human uterus (Huszar & Naftolin,1984). The longitudinal muscle layer in cross section 
appears as muscle bundles that run the length of the uterine tube, whereas the inner 
circular muscle layer, located next to the endometrium, runs circumferentially around 
the uterine horn. Both myometrial layers are fed by an extensive layer of blood vessels, 
known as the vascular plexus, which runs between the two layers (Shynlova et al., 2005; 
Williams et al., 2010; Figure 1.1). 
 
 
  
 
 
 
 
Figure 1.1 Diagrammatic representation of the rat uterus.  On the left is a diagram representing a 
pregnant rat uterus. On the right is a non-pregnant rat uterus. On the bottom is a representation of 
a cross section of a rat uterine horn showing all the muscle layers. The smooth muscle is 
composed of two layers, an outer longitudinal layer and an inner circular layer. Under a light 
microscope, the longitudinal layer in cross section appears as muscle bundles while the circular 
layer encircles the length of the tube next to the endometrium. Both layers work in unison to 
expel the fetus by producing strong contractions during parturition. Figure from Peach, 2010. 
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1.3 Regulation of Smooth Muscle Contraction 
The smooth muscle cells (SMCs) of the uterus are composed of actin-containing 
thin filaments and myosin-containing thick filaments arranged in long bundles that 
extend around the periphery of the cell.  Hence, they are not arranged in sarcomeres like 
other muscle types (Guilford & Warshaw, 1998). A third filament, the intermediate 
filament, has also been found in the cytoplasmic space of smooth muscle and is thought 
to act as anchorage sites for these thick and thin filaments (Bond & Somylo, 1982). It is 
this arrangement that allows for the sliding-filament crossbridge theory to be applied to 
uterine smooth muscle. This means that uterine contraction depends upon the interplay 
between these muscle fibres arranged approximately between successive myocytes 
(Kelly & Rice, 1969; Mounier & Arrigo, 2002).  
In SMCs there are two predominant forms of actin, α- and γ-actin (Aguilar & 
Mitchell, 2010).  Smooth muscle also has a different type of myosin, where the ATPase 
activity is much slower, which decreases the rate of crossbridge cycling and lengthens 
the contraction phase.  This type of myosin contains regulatory protein chains, called 
myosin light chains (MLC), located in the neck region of the myosin filament. These 
elements of the cytoskeleton have several functions in terms of structure and flexibility 
that help to generate force from the muscle fibres (Herrera et al., 2005; Silverthorn, 
2010).  
The contractile cycle of activation, involving these actin and myosin filaments 
for smooth muscle depends heavily on the movement of several ions; Na+, Ca2+ and Cl- 
ions moving into the cytosolic compartment from the extracellular space, and movement 
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of K+ ions into the extracellular space from the cytosolic compartment (Taggart & 
Morgan, 2007). When the cytosol experiences an increased concentration of calcium, 
depolarization occurs, and thus the contraction cycle is initiated (Wray, 1993). The 
sarcoplasmic reticulum releases the calcium, which then enters the cytoplasmic fluid 
(Garfield & Maner, 2007). The next step involves a cytosolic calcium binding protein, 
calmodulin, which is activated upon the binding of four calcium ions. This is an 
additional difference from skeletal muscle in which calcium binds to troponin, which is 
lacking in smooth muscle (Silverthorn, 2010). The calcium-calmodulin complex 
activates the enzyme myosin light chain kinase (MLCK) by inducing a conformational 
change. In the presence of ATP, MLCK can then phosphorylate the MLCs, located in 
myosin heads (Aguilar & Mitchell, 2010). Specifically, MLCK will phosphorylate 
Serine 19 on MLC and it causes another conformational change. The conformational 
change occurs in the neck region of the heavy chains of the myosin motor. This is 
change in shape is what allows for the formation of the crossbridges between actin and 
myosin filaments (Aguilar and Mitchell, 2010). The myosin motor chains also undergo a 
conformational change from their folded state to an extended state. This allows for the 
myosin crossbridges to be able to slide along the actin filaments and thereby create 
muscle tension, or what is known as a power stroke (Taggart & Morgan, 2007). Once 
the calcium levels decrease, the smooth muscle relaxes until the next stimulus causes the 
cycle to start again (Silverthorn, 2010; Figure 1.2). 
 
 
  
 
 
Figure 1.2 Smooth muscle components involved in contraction. Myosin thick filaments and 
actin thin filaments are anchored to dense bodies and comprise the contractile elements of 
smooth muscle. The movement of the actin thin filaments is caused by phosphorylation of 
myosin light chains followed by ATP hydrolysis by the myosin II ATPase. Myosin II, 
composed of two heavy chains, two light chains and two regulatory light chains, gets 
phosphorylated forming a cross bridge between the actin and myosin filaments. This cross 
bridge formation also changes the angle of the neck region of myosin, causing motion of the 
actin thin filaments, which ultimately results in shortening of the cell. Thus, the ATP 
hydrolysis by myosin II ATPase causes the distance between the anchor points to decrease, 
resulting in contraction. Figure from Aguilar and Mitchell, 2010 (Appendix B). 
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1.4 Parturition 
While the mechanism of smooth muscle contraction, and how it is used to expel 
the fetus, is understood, the exact mechanism(s) of what initiates human parturition is 
not fully understood; however, the general sequence of events in parturition are known. 
Once contractions begin, a positive feedback loop involving hormonal and mechanical 
factors is initiated. It is thought that these mechanical factors, namely the initial uterine 
contractions, are what causes the first release of oxytocin from neurons in the 
hypothalamus, which are upregulated during late pregnancy (Carson et al., 2013). The 
fetus, usually head down, moves to the lower abdomen and is pushed on the already 
softened cervix promoting a neuroendocrine reflex that stimulates oxytocin secretion 
from the pituitary, which drives uterine contraction. Thus, the pushing on the cervix 
instigates a positive feedback loop to release more oxytocin, causing stronger and more 
frequent contractions to occur (Neumann et al., 1996). The wave of contraction starts 
from the top of the uterus and moves downwards towards the cervix to push the fetus 
further down towards the pelvis. There is also evidence that this increase in oxytocin 
secretion may stimulate production of prostaglandins in the uterus that cause even 
further contractions to help expel the fetus (Blanks & Thorton, 2003). 
The contractions intensify even more, and push the fetus through the vagina and 
out of the maternal body. The placenta, then unattached from the fetus, is expelled a 
little later (Silverthorn, 2010). Despite a sound understanding of the events involved in 
parturition, the exact molecular mechanisms regulating the transition of the normally 
quiescent myometrium into a powerful, contractile tissue remain poorly understood. It is 
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this limited knowledge that restricts the treatments for preterm labor (López Bernal, 
2007).  
 
1.5 Phases of Myometrial Differentiation 
Throughout pregnancy, the uterus, especially the myometrium, undergoes several 
changes and remodels to accommodate the growing fetus (reviewed by Challis et al., 
2000). As a result of mechanical stretch and hormonal influence, the SMCs of the 
myometrium differentiate through four separate phases during gestation: an early 
proliferative phase, an intermediate synthetic phase, a phase where cells assume a 
contractile phenotype, and the final phase where the cells become highly active and 
committed to labour (Shynlova et al., 2009). Since this thesis is focused around the rat 
model of the uterus, this section will concentrate on the phases of rat myometrial 
development (Figure 1.3). 
1.5.1 Proliferative Phase 
 The proliferative phase of myometrial development occurs from d1 of pregnancy 
until approximately d14. Proliferation is described as a period of rapid uterine myocyte 
proliferation; also termed hyperplasia. This increase in cell number occurs 
predominantly in the longitudinal layer of both gravid and non-gravid horns of 
unilaterally pregnant rats, which suggests the stimulant of this phase may be primarily 
endocrine related and not induced by mechanical signals (Shynlova et al., 2006). The 
uterine muscle proliferation was confirmed by Shynlova and colleagues (2006) when  
  
 
 
Figure 1.3 The phases of myometrial differentiation over gestation. From NP- d14 the uterus 
is in the proliferative phase which is characterized by an increase in cell number, also known 
as hyperplasia. During this phase, the myometrial smooth muscle cells (SMCs) proliferate. 
From approximately d14-d21 the uterus enters the synthetic phase, where the cells no longer 
increase in number, but rather in size. In particular, cells associated with the extracellular 
matrix are associated with this increase in size, or hypertrophy. d21 marks the transition into 
the contractile phase, where the myocytes begin to develop into a contractile phenotype. This 
stage lasts until d23 when the rat is in labour. When in labour, the myometrium is highly 
active and responsive to uterine agonists. This active uterus is then able to form coordinated 
contractions which eventually lead to the expelling of the fetus. Figure adapted from Peach, 
2010. 
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they detected an increased incorporation of 5-bromo-2’-deoxyuridine incorporation, a 
well-known indicator of hyperplasia, in uterine myocytes during the early phase of 
pregnancy.  
 Endocrine signals, such as 17β- Estradiol and the insulin-like growth factor (IGF) 
system play an important role in regulating the cell proliferation cycle in various tissues 
(Le Roith, 2003; Yin et al., 2007). In fact, both the 17β- Estradiol and IGF-I signalling 
pathways have been shown to be interconnected in human endometrial cancer models 
whereby IGF signalling was blocked and resulted in a reduced proliferative effect of 
17β- Estradiol in the human endometrium cells (Gielen et al., 2005). Also, Lye and 
colleagues (2001) showed in non-pregnant models that myometrial proliferation is 
induced by estrogen-regulated growth factors like IGF-1 and EGF. Both factors are able 
to induce cell proliferation in reproductive tissues by a cascade of reactions initially 
through phosphorylation of insulin receptor substrate (IRS) and recruitment of 
phosphoinositide-3-kinase (PI3K; Jaffer et al., 2009). Protein kinase B (Akt) is 
subsequently phosphorylated and positively regulates the mammalian target of 
rapamycin (mTOR). mTOR is a serine/threonine kinase that is critical in the growth and 
development of cells (reviewed by Cornu et al., 2013). mTOR forms two multiprotein 
complexes which have slightly different functions in cellular development; mTORC1 
results in activation of transcription, ribosome biosynthesis and protein synthesis,  
whereas mTORC2 regulates the actin cytoskeleton and cell polarity (Wullschleger et al., 
2006). 
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 Once mTORC is activated, it too will activate several downstream targets that are 
known to initiate and promote processes such as translation, which would result in an 
increase in cell number. One such target of mTOR is S6-kinase-1 (S6K1), a kinase that 
phosphorylates S6, a protein component of the 40S ribosomal subunit (Ruvinsky et al., 
2005). Once S6 is phosphorylated, it becomes activated and results in an increase in both 
ribosomal biogenesis as well as cellular capacity for protein synthesis (Lee et al., 2007).  
 Jaffer et al (2009) analysed the protein levels of PI3K, mTOR and S6K1 
throughout gestation in the rat myometrium. They found that the phosphorylated forms 
of these three proteins were highly upregulated during the proliferative phase of 
gestation, which strongly suggested that activation of the PI3K/mTOR pathway was 
responsible for the induction of myometrial hyperplasia during early gestation. It was 
further demonstrated that inhibition of mTOR signalling in the myometrium through the 
administration of rapamycin to pregnant rats, reduced the number of proliferating cells 
in the pregnant rat myometrium which confirmed the vital role of mTOR in proliferation 
of the tissue (Jaffer et al., 2009). 
 The total increase in cell number during proliferation depends on the balance 
between total cell production and total cell loss. Specifically during the proliferative 
phase, one would expect to see an increase in mitotic activity accompanied by a decrease 
in programmed cell death, i.e. apoptosis (Shynlova et al., 2006). Since the proliferative 
phase is concerned mainly with the increase in cell number, the amount of cell death, or 
apoptosis, must be regulated. Apoptosis is defined as a physiological process by which 
excess or dysfunctional cells are removed during development or normal tissue 
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homeostasis (Vandaele & Van Soom, 2011). This process becomes particularly 
important in dynamic systems, such as reproduction and in many tissues like the 
placenta, the endometrium, mammary glands, and the myometrium (Leppert, 1998; Mu 
et al., 2002).  In fact, some anti-apoptotic factors have been shown to be highly 
expressed during the proliferative phase, such as Bcl-2.  It is thought that it has a role in 
contributing to the overall increase in cell number by decreasing the level of apoptosis 
and therefore allowing cell proliferation to occur (Shynlova et al., 2009).  
1.5.2 Synthetic Phase 
 While the proliferative phase is a period of uterine growth caused by an increase 
in cell number, the subsequent synthetic phase is due to an increase in cell size known as 
hypertrophy (Shynlova et al., 2009). In the rat, it occurs from approximately day 15 to 
approximately day 21 and is marked by an increase in the protein:DNA ratio of the 
myometrium as well as a marked increase in the thickness of the uterine muscle 
(Shynlova et al., 2006).  It is a period of time where there is significant synthesis and 
deposition of the interstitial matrix through expression of interstitial matrix proteins such 
as collagen I (Harkness & Harkness, 1954). In fact, Shynlova and colleagues (2004) 
showed a peak in the expression of fibrillar collagens (type I and III) at d19 during rat 
gestation which then decreased until labour. This extra-cellular matrix (ECM) is 
required to form the ground substance of the myometrium, which plays a crucial role 
during labour (White et al., 2011).  Furthermore, this hypertrophic phase is characterized 
by: an increase in cellular protein synthesis such as thick, thin and intermediate 
filaments, increases in cellular organelles such as mitochondria, and finally a transition 
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into a more contractile phenotype which varies in protein content and organization 
(Shynlova et al., 2006).  
 The synthetic phase has also been found to coincide with the activation of 
apoptotic cascade machinery (Shynlova et al., 2006).  Several apoptosis-promoting 
caspases such as 3, 6 and 7 are upregulated near the beginning of the synthetic phase; 
however, Shynlova et al (2006) showed, through terminal deoxynucleotidyl transferase 
dUTP nick end labeling (TUNEL), that labels terminal ends of fragmented deoxynucleic 
acid (DNA), that there was no evidence of apoptosis occurring in the rat myometrium. 
Thus, these caspases may have additional unknown roles in the myometrium at this 
time.  
During this phase there is enhanced expression of focal adhesions, which aid in 
critical cell-ECM communication as the cells get bigger. Focal adhesions are clusters of 
integrin receptors that are the sites where extracellular ligands are coupled to 
cytoplasmic F-actin, (a major component of muscle fibre thin filaments) allowing for 
critical cell-matrix interactions to occur, which will become crucial for proper regulation 
of the subsequent contractile and labour phases (Williams et al., 2005; Shynlova et al., 
2009). This adhesion formation also involves the interaction of several signaling 
proteins such as FAK, paxillin and adapter proteins like vinculin (MacPhee & Lye, 
2000). It is also associated with an increased expression of ECM proteins, which are 
crucial to anchor other growing cells to the surrounding matrix proteins. During this 
phase, several different types of ECM molecules can be found in uterine muscle like 
collagen type IV, laminin and fibronectin (Shynlova et. al, 2009).  
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 The major regulators of myometrial growth during the synthetic phase were 
recently determined by Shynlova et al (2010). They were able to directly correlate the 
extensive rat myometrial growth during this stage of pregnancy with a threefold increase 
in myocyte size. Through stretch studies using the unilaterally pregnant rat model, they 
were able to determine that the major cause of this growth was uterine distension caused 
by the fetus in normal gestation. The stretched (pregnant) horn of the uterus had a 
myocyte volume approximately 3-fold larger than the non-gravid (non stretched) horn. 
 Although the synthetic phase is clearly dependent on physical influences, 
hormones, such as progesterone are also important in regulating the synthetic phase of 
myometrial development in the rat (Shynlova et al., 2004). Progesterone has several 
crucial roles in the myometrium during gestation such as support of uterine growth, 
matrix synthesis and the inhibition of contractile associated protein (CAP) expression. 
Lye and colleagues (2001) showed for example that when mifepristone (RU486), a 
competitive progesterone receptor antagonist, was administered during this period, 
hypertrophy was significantly reduced. Shynlova and collegues (2004) also 
demonstrated that administering RU486 to pregnant rats during the synthetic phase at 
d17 resulted in an interruption of hypertrophy and poor uterine development.  
Essentially, progesterone is important for the cessation of labour, as removal of the 
source of progesterone earlier than day 23 in the rat results in termination of pregnancy 
(Ou et al., 1998). Progesterone also appears to be a crucial regulator of several genes 
encoding ECM proteins required to form the aforementioned interstitial matrix such as 
collagen I, collagen III and elastin as inhibition of progesterone action resulted in 
decreased expression of these proteins (Shynlova et al., 2007). 
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1.5.3 Contractile Phase 
At approximately day 21 of pregnancy the myometrium transitions into the 
contractile phase, a phase dedicated to preparing the uterus for labour. Here, hypertrophy 
has stabilized and there are marked changes around the myocyte, but also in the 
interaction between the myocyte and the underlying matrix (Shynlova et al., 2009). 
Another change is that proteins that were expressed earlier in gestation are now 
expressed as different isoforms. For example, more γ-actin is expressed in this phase 
compared to the α-smooth muscle actin expressed in non-pregnant situations (Shynlova 
et al., 2005).  
Although the exact mechanism by which this phase arises is unknown, Shynlova 
et al. (2010) have previously shown that this phase may be regulated by mechanical 
stretch in the uterus caused by the growing fetus. In a unilateral stretch study, it was 
reported that the gravid, or stretched, horn produced increased levels of caspase 3 
(CASP3), an effector protein that cleaves cellular substrates and promotes 
morphological changes and/or cell death in the myometrium. The upregulation of this 
protein in the gravid horn suggests that stretch is important in cellular differentiation in 
the uterus (Shynlova et al., 2010). 
The transition into this phase is also marked by a distinct change in the synthesis 
of matrix proteins, specifically those that form the basement membrane to which the 
myocytes will anchor themselves in order to ensure cohesive contractions throughout the 
myometrium (Robinson et al., 2004; Williams et al., 2005). Shynlova and colleagues 
(2009) demonstrated a significant upregulation of fibronectin (FN), laminin β2 and 
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collagen IV expression that coincided with the initation of the contractile phase and the 
expression of these proteins remained high until term. They showed using 
immunofluorescent detection procedures that during the synthetic phase, these proteins 
were only detectable sporadically around myocytes, however, during the contractile 
phase they were detected as continuous and organized structures. 
Like other phases in myometrial development, this phase is regulated by both 
hormonal and mechanical influences. This was shown in an earlier study by Shynlova 
and colleagues (2004). Through unilateral stretch studies, the increased expression of the 
aforementioned proteins was found to occur as a result of a drop in progesterone levels.  
In fact, when RU486 was administered before d21 in pregnant rats it induced the switch 
from interstitial matrix protein synthesis to basement membrane protein synthesis. The 
authours observed an increase in mRNA levels of collagen IV, fibronectin and laminin,. 
They also found that this increase in basement membrane protein expression only 
occurred in the gravid horn, which strongly implied that uterine stretch regulated 
expression of these proteins.  
1.5.4 Labour 
 At approximately d23 of gestation, the myometrium switches into the final phase 
of development, the labour phase. This stage is marked by a decrease in the levels of 
progesterone and is the stage where the myometrium becomes fully committed to the 
development and execution of intense coordinated contractions, which will result in the 
expulsion of the fetus (Lye et al., 2001).  In order to evoke these coordinated 
contractions, the phenotype of the SMCs must change in order for these cells to interact 
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in a more synchronized manner. This is elicited, at least in part, through the FAK 
signalling pathway.  During labour, a notable decrease in FAK activity has been reported 
in the rat myometrium, which may suggest that myocytes are anchoring to the basement 
membrane (MacPhee and Lye, 2000). It has been shown that decreased FAK activity is 
associated with the formation of stable SMC-ECM interactions which form focal 
adhesions and thus connect the ECM matrix to the actin cytoskeleton through clusters of 
integrin molecules (Ilić et al., 1995).  This anchorage reinforces the ligand-integrin 
interaction, which through cell-ECM communication will allow for smooth muscle 
cohesive contractions during labour (Shynlova et al., 2009). Essentially, these now 
formed focal adhesions act as the primary points for force transduction, and thereby allow 
the myocytes to work as a mechanical syncytium (Williams et al., 2005). 
During the contractile phase, uterine growth has ceased but fetal growth 
continues, which places an enormous tension on the myometrium. This stress will signal 
the expression of a cassette of genes to form contractile associated proteins (CAPs) such 
as the sodium channel, oxytocin receptor, prostaglandin F receptor, and Cx43 which is a 
gap junction protein needed to increase the electrical excitability of myocytes (reviewed 
by Shynlova et al., 2009, Mitchell & Lye, 2002; Ou et al., 1997; Ou et al., 1998). CAPs 
are thought to be substances that modulate myometrial tone and contractility within the 
myometrium throughout labour. For example, Lye et al (1993) found that Cx-43 
transcripts in the rat myometrium were low or undetectable throughout most of 
pregnancy, but increased dramatically immediately before the onset of labor. It is thought 
that Cx-43 like other CAPs mediate the increased electrical coupling between cells within 
the myometrium during labor. Ou et al (1998) showed however that increased uterine 
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stretch and a decrease in progesterone levels are not adequate to induce expression of 
these labour dependent genes. Insertion of a polyvinyl tube at d17 in the rat myometrium, 
while progesterone levels were still high, did not induce labour. Similarly, administration 
of exogenous progesterone on d20, when uterine stretch was high, blocked labour or 
expression of CAPs as progesterone promotes relaxation, not contraction. Therefore, it 
has become widely understood that the labour phase is dependent on both mechanical and 
endocrine influences. 
 
1.6 Small Heat Shock Proteins 
In almost all organisms, from bacteria to humans, small heat shock proteins 
(sHsps) are ubiquitously distributed and their expression is induced by a multitude of 
stresses (Laskowska et al., 2010). To date, 10 sHsps (HspB1- HspB10) have been 
identified in mammals, with different but highly important roles (Golenhofen et al., 2004; 
Orejuela et al., 2007; Table 1.1). For example, HspB8 and HspB1 have been shown to 
have opposing functions with respect to apoptosis; HspB8 shows a pro-apoptotic activity 
in a cell-specific manner while HspB1 has an anti-apoptotic action both upstream and 
downstream of the apoptosome (Gober et al., 2003). In addition to heat, sHsps 
functionally respond to oxidative stress, osmotic stress, cold shock and heavy metals 
(Gusev et al., 2005; Laskowska et al., 2010). 
 Typically these small stress proteins are 15-40 kDa in size and are able to form 
large oligomeric complexes (Orejuela et al., 2007). The basic monomeric structure of all 
sHsps contains a conserved ~90 amino acid α-crystallin domain, which is found in the  
  
 
 
 
 
 
 
Table 1.1 Characteristics and tissue distribution of mammalian small heat shock proteins 
(sHSPs). Adapted from Hu et al., 2007.  
 
 
  
  
 
Protein name 
(old nomenclature in 
parenthesis) 
pI Mass (kDa) Length (aa) Tissue 
distribution 
HspB1 (Hsp27) 
 
6.4 22.8 205 Ubiquitous 
HspB2 (MKBP) 4.8 20.2 182 Heart and 
muscle 
HspB3 5.9 17.0 150 Heart and 
muscle 
HspB4 (αA/CRY!AA) 6.2 19.9 173 Eye lens 
 
HspB5 (αB) 7.4 20.2 175 Ubiquitous 
 
HspB6 (Hsp20) 6.4 16.8 157 Ubiquitous 
 
HspB7 (cvHsp) 6.5 18.6 170 Heart and 
muscle 
HspB8 (H11/Hsp22) 4.7 21.6 196 Ubiquitous 
 
HspB9 9.0 17.5 159 Testis 
 
HspB10 (ODF1/ODF27)  30 262 Testis 
 
 
Defined abbreviations: pI= Isoelectric point, kDa= kilodaltons, aa= Amino Acids.! !
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form of a β-sheet sandwich that dimerizes to form the basic functional unit of all sHsps. 
These β-sheets are composed of two layers of three and five antiparallel strands that are 
connected but an interdomain loop (van Montfort et al., 2001). Oligomerization then 
becomes possible because of the amino- and carboxy- terminal end of the monomers 
(Leroux et al., 1997). These oligomers have many different structures and are essential 
in the chaperone functions of sHsps (Laskowska et al., 2010).  In fact, many sHsps must 
undergo phosphorylation and then subsequent oligomerization into multimeric 
complexes in order to evoke any function, but especially as molecular chaperones 
(Bruey et al., 2000; Arrigo et al., 2007). For example, Bruey et al, (2000) showed that 
when a mutated form of Hsp B1 was unable to form large oligomers, its protein 
expression and function was greatly reduced in colorectal cancer REG cells compared to 
cells that did not possess a mutated Hsp B1 protein. 
Furthermore, most Hsps undergo some form of post-translational modifications, 
which influence the function of Hsps, such as deamidation, acylation, and most 
commonly, phosphorylation (Groenen et al., 1994; Gaestel 2002).  For example, HspB1 
has been shown to undergo crucial phosphorylation on three different serines, S15, S78 
and S82. Phosphorylation on these sites can influence both the structure and function of 
HspB1, such as oligomerization, which is dependent on this post-translational 
modification (Landry et al., 1992). For example, phosphorylation of these sites has been 
shown to increase the molecular chaperone activity and thermotolerance of HspB1 
(Thériault et al., 2004) 
As ATP-independent chaperones, most sHsps bind misfolded proteins and 
prevent the formation of aggregates. They maintain protein solubility in times of stress 
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until other chaperones can refold them to their native state (Ehrnsperger et al., 1997). 
For example, HspB5 is one of the most abundant proteins in the mammalian eye lens to 
prevent protein aggregation, which may lead to the formation of cataract (Horwitz, 
2009).  Furthermore, these chaperones may have an important function in smooth 
muscle, such as the myometrium. An investigation by White et al., (2005) demonstrated 
that in the rat myometrium HspB1 has a potential role as a CAP as its mRNA expression 
has a distinct pattern of expression; peaking at d19 of rat gestation and then decreases 
until labour. Immunoblot analysis also showed that HspB1 has high protein expression 
late in pregnancy between day 21 and 1 day post-partum (PP) inclusive. Another study 
by Cross et al (2007) showed HspB6 was also present in the myometrium. Both HspB6 
mRNA and protein expression decreased near the end of gestation, during labour and 
PP. This could indicate that HspB6 has a role in smooth muscle relaxation. While both 
HspB1 and HspB6 proteins have distinct patterns of expression throughout gestation, it 
remains unknown as to what is regulating their expression. Salinthorne et. al (2008) 
suggested that under normal conditions sHsps help maintain smooth muscle function 
such as maintaining cytoskeletal structure, normal redox conditions and regulating 
translation, whereas under times of stress, such as disease, they are responsible for 
helping the smooth muscle adapt to stress. 
 
1.7 Heat Shock Transcription Factors 
In order to maintain homeostasis in times of stress, a first line of cellular defense 
for an organism is a heat shock response (HSR), which results in the induced expression 
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of several Hsps (Akerfelt et al., 2007). This response is carefully regulated by a family 
of transcriptional activators, called heat shock transcription factors (Hsfs) which were 
discovered in the 1980s (Wu, 1984). In mammals, three active Hsf homologues are 
found: Hsf1, Hsf2, and Hsf4 (reviewed by Akerfelt et al., 2010).  Each Hsf plays a 
different role in the HSR, but combined, form the required machinery for the specific 
transcription and translation of stress-related genes (Anckar & Sistonen, 2007).  
Hsfs all have the same general structure, which is composed of several different 
functional domains (Akerfelt et al., 2010). The first domain is the DNA-binding domain 
(DBD) which is the best preserved domain in all Hsfs and is considered to be the 
signature domain for the family. It forms a compact globular structure and has a flexible 
loop that is located between β-strands 3 and 4. This loop is what allows for critical 
protein-protein interactions between other subunits of the Hsf trimer (Damberger et al., 
1994). Trimer formation in turn results in high-affinity DNA binding. Hydrophobic 
heptad repeats (HR-A and HR-B) also assist in Hsf trimerization. They form a coiled coil 
structure, similar to that in a leucine zipper (Sorger & Nelson, 1989). This trimerization is 
inhibited by another hydrophobic repeat, HR-C (Rabindran et al., 1993).  At the carboxyl 
terminus of all Hsfs, with the exception of yeast, is the transactivation domain (AD). The 
transactivation domain is composed of two modules, AD1 and AD2, which are rich in 
hydrophobic and acidic residues. Together these residues ensure a rapid and prolonged 
response to stress (Newton et al., 1996; Figure 1.4). 
The HSR is a well understood process in all mammals. First the Hsfs all undergo 
some form of posttranslational modification, such as phosphorylation and sumoylation. 
Phosphorylation occurs in the regulatory domain of Hsfs, and has only been shown to  
  
 
 
Figure 1.4 A modular representation of the heat shock factor 1 (Hsf1) protein. Hsf1 contains a 
DNA-binding domain (DBD), three heptad repeats (HR-A, HR-B and HR-C), a phosphorylation-
dependent sumoylation motif (PDSM), a Regulatory domain (RD), and two activation domains 
(AD1 and AD2). The figure shows the DBD and several of the post-translational modification 
sites. The effect of acetylation on Lys-80 is still unknown however it is thought that this 
modification may prevent the DBD from binding to the HSE on target genes. Phosphorylation on 
Ser-230 causes an increase in the trans-activation capacity of Hsf1 whereas phosphorylation on 
Ser-303 and Ser-307 causes a loss of the transactivation capacity of Hsf1. Sumoylation is the 
addition of small ubiquitin like modifier (SUMO) protein which also results in a loss in the 
transactivation capacity of Hsf1. This modification is often mediated by phosphorylation on site 
Ser-303. From Akerfelt et al., 2010. 
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occur on serine (Ser) residues. Some examples of known phosphorylation sites are Ser 
230, 303, and 307 (Knauf et al., 1996). Sumoylation occurs in a special motif, located in 
the regulatory domain, known as the phosphorylation-dependent sumoylation motif. It 
consists of an amino acid consensus sequence of I/L/ V-K-X-E-X-X-S-P and is located 
around amino acid position 297−304. It is implicated in repressing the transactivating 
capacity of Hsf1 (Hietakangas et al., 2006). The type of post-translational modification 
that does occur depends on what Hsf members are being activated. Once activated, the 
Hsfs often transition from their monomeric form to either a dimer or a trimer in an Hsf-
specific manner (Akerfelt et al., 2007). Once fully activated, the Hsf binds to one of the 
multiple copies of a heat shock element (HSE) found in the promoter region of several 
Hsps and stress-inducible genes (Trinklein et al., 2004). HSEs all possess multiple 
inverted repeats of the same conserved sequence nGAAn. The DBD on the Hsf 
recognizes this HSE in the major groove of the double helix and binds to it (Akerfelt et 
al., 2007). Since the target gene contains more than one HSE, it allows Hsfs to bind 
cooperatively– when one Hsf binds, it facilitates the binding of the next transcription 
factor (Anckar & Sistonen, 2007; Figure 1.5).  
 
1.8 Hsf1  
Of the three mammalian Hsfs, Hsf1 is the recognized stress-responsive 
prototype. Its role cannot be replaced by any other Hsf, since mice that lacked Hsf1 had 
no HSR whatsoever (McMillian et al., 1998; Xiao et al., 1999; Akerfelt et al., 2007).  
 
  
 
 
 
 
Figure 1.5 The mechanism of Hsf action. First Hsfs undergo some form of post-translational 
modification, such as phosphorylation and sumoylation. Once activated, the Hsfs often 
transition from their monomeric form to either a dimer or a trimer. Once fully activated, the 
Hsf binds to one of the multiple copies of heat shock elements (HSE) found in the promoter 
region of several heat shock proteins (Hsps) and stress/developmentally-inducable genes. 
Since the target DNA contains more than one HSE, it allows Hsfs to bind cooperatively– 
when one Hsf binds, it facilitates the binding of the next transcription factor. This all leads to 
the up-regulation of Hsps or other developmental genes, thus initiating the heat shock 
response (HSR).  Adapted from Trepel et al., 2010. 
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Under non-stressed conditions, Hsf1 remains in an inactive monomeric form in 
the nucleoplasm and to a much smaller extent in the cytosol (Anckar & Sistonen, 2007). 
Intramolecular interactions between the many leucine zippers present on Hsf1 are able to 
help stabilize and keep the protein in this inactive state (Cotto, 1996). Any number of 
developmental cues can cause Hsf1 to be activated, as long as they generate an increased 
number of non-native proteins (Anckar & Sistonen, 2007). Hsf1 is activated in the same 
way as all other Hsfs, including trimerization, movement to the nucleus and then binding 
to DNA (Akerfelt et al., 2007). Hsf1 can bind to any gene that contains a HSE in their 
promoter region and the HSE must also allow Hsf1 to bind in either its dimeric or 
trimeric form (Pirkkala et al., 2001). Hsf1 initiates the transcription of several Hsps, 
which act as molecular chaperones, such Hsp70, Hsp90 and HspB1 (Nadeau et al., 1993; 
Rasmussen & Lis, 1993; Holbrook & Udelsman, 1994).  These Hsps start a negative-
feedback loop and are able to inhibit any further activation of Hsf1 until another HSR is 
required (Westerheide et al., 2009). However, simply binding of Hsf1 to the target gene 
is not enough to activate transcription, but the exact mechanism of transcriptional 
activation by Hsf1 is still poorly understood. The best studied is the activation of Hsp 
70; however Fossati et al (2006) has indicated that the mechanism of action is likely 
species and tissue specific. When a cell is exposed to heat shock, Hsf1 binds to HSEs in 
the promoter region of Hsp 70 and this binding then causes recruitment of positive 
transcription elongation factor b (P-TEFb) (Marshall et al., 1996). P-TEFb 
phosphorylates the C-terminal domain of RNAP II as well as the DRB sensitivity-
inducing factor (DSIF) and the negative elongation factor (NELF) (Brès et al., 2008). 
This, in turn, causes the removal of NELF from the RNAP II, thereby facilitating 
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transcriptional elongation. Furthermore, the binding of Hsf1 to the HSE also results in 
an initial round of nucleosome displacement, which is regulated by the enzymatic 
activity of poly(ADP)-ribose polymerase 1 (PARP-1; Petesch et al., 2008). RNAP II 
moves across the hsp70 gene as transcription-dependent chromatin arrangement occurs, 
which is likely facilitated by the actions of several histone assembly/reassembly factors 
such as suppressor of Tyrosine 6 and Facilitates Chromatin Transcription complex 
(Saunders et al., 2003; Ardehali et al., 2009; Figure 1.6). 
In its trimeric form, Hsf1 was found to be heavily phosphorylated on at least 12 
different serine residues located in its regulatory region (Guettouche et al., 2005). This 
phosphorylation of Hsf1 is most often a direct result of HSR activation (Jurivich et al., 
1995). Currently, there are only two known phosphorylation sites on Hsf1 which lead to 
transactivation, Ser-230 and Ser-236 (Holmberg et al., 2001; Boellmann et al., 2004). 
These phosphorylation sites are thought to act as a switch that can overcome the 
inhibitory effect of the regulatory domain on the Hsf1 transactivation capacity (Anckar 
& Sistonen, 2007); however, it should be noted that although phosphorylation is the 
main form of Hsf1 activation, phosphorylation is not solely responsible for the initiation 
of transcriptional activity. In fact, phosphorylation of several sites, including Ser-303 
and Ser-307, in the regulatory domain actually inhibit the transcriptional activity of Hsf1 
(Knauf et al., 1996; Kline & Morimoto, 1997). These phosphorylated sites maintain 
Hsf1 in its inactive state, only to be overridden by heat shock (Anckar & Sistonen, 
2007). 
Although present in both higher invertebrates and vertebrates, Hsf1 is not 
required for survival; however it is required to maintain a normal body size, sufficient  
  
 
Figure 1.6 Mechanism of Hsp70 gene activation with and without heat shock. A) In the 
absence of stress, the Hsp70 gene is not transcribed. RNA Polymerase II (RNAP II) is bound 
to a region 20-40 base pairs down stream of the transcription start site (TSS). In this position, 
it is kept inactive by the DRB sensitivity-inducing factor (DSIF) and the negative elongation 
factor (NELF). B) However in the presence of heat shock or stress, the transcription of the 
Hsp70 gene is allowed to occur. Hsf1 binds to the HSEs located in the promoter region, and 
this causes a recruitment of the positive elongation factor b (P-TEFb). P-TEFb promotes 
transcriptional elongation through its ability to phosphorylate RNAP II, DSIF and NELF, 
which results in the dissociation of NELF from RNAP II. Concurrently, Hsf1 also regulates 
the enzymatic activity of PARP-1 which once activated causes rapid nucleosome 
displacement. Adapted from Anckar & Sistonen, 2011. 
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embryonic development and to prevent many reproductive disturbances (reviewed by 
Anckar & Sistonen, 2007). Specifically, Hsf1 null mouse embryos showed no extensive 
defects; however, the placenta was found to have abnormal architecture, suggesting a 
problem with the extra-embryonic tissue. Upon mating Hsf1-/- female with wild type 
male mice, no fertilized oocytes developed past the zygotic stage with two pronuclei and 
a second polar body. These two results show that Hsf1 is a maternal factor, necessary for 
early postfertilization development (Christians et al., 2000).  Therefore, it was concluded 
that a disturbance in maternal Hsf1 could be one cause of infertility and high prenatal 
lethality in mammals (Anckar & Sistonen, 2007). 
  Several cancer studies have shown that in certain carcinomas, Hsf1 may in fact 
induce increased proliferation of tumour cells (Dai et al., 2007; Santagata et al., 2011). 
The exact mechanism for this is still poorly understood; however, it is thought that in the 
malignant state, the tumour cells endure a variety of stressors like hypoxia, acidosis, 
nutrient depletion, as well as immune attacks from the host, that lead to drastic changes in 
core cellular physiology that are hallmarks of cancer. Hsf1, being a stress-responsive 
protein, may permit cancer cells to cope with the stressors, allowing tumour cells to 
reconfigure their metabolism and protein homeostasis.  Once homeostasis is maintained 
through Hsf1, only then can tumour cell proliferation occur. Calderwood and Gong 
(2011) have recently proposed a more causative effect; that Hsf1 protein expression 
increases as a result of pre-existing proliferation in order to initiate the HSR as a result of 
stress caused by the increased proliferation. 
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1.9 Objectives; Hypothesis 
Very little information exists on the expression or the roles of Hsf1 in the rat 
myometrium during pregnancy. Previous work in the lab by Bryan White and Brandon 
Cross has shown expression of Hsf1 target genes HspB1 and HspB6, in the rat 
myometrium during pregnancy. Both proteins have robust expression in mid-gestation, 
however what regulates their expression remains unknown. Therefore, since HspB1 and 
HspB6 are Hsf1 target genes, the goal of this thesis was to characterize Hsf1 expression 
in the rat myometrium throughout pregnancy and to investigate a possible correlation 
between Hsf1 expression and the production of various Hsps throughout rat gestation. It 
was hypothesized that Hsf1 would be highly expressed in the myometrium during 
pregnancy and that it could be important during the proliferative phase of myometrium 
differentiation to activate expression of key genes necessary for this phase. 
 
Significance: The expression of Hsf1 has never been examined in the myometrium, so 
the work described in this thesis will add novel data to the Hsf1 research field in 
defining the expression of Hsf1 in smooth muscle containing tissues. Hsf1 patterns of 
expression may also provide some clue as to what Hsps are upregulated as a result of 
Hsf1 expression.  
 
 
General Research Plan:  
 
I. To investigate if total Hsf1 protein expression changes temporally and/or spatially 
throughout gestation in the rat myometrium.  
II. To determine the regulation of Hsf1 expression in the myometrium. 
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III. To perform in vitro experiments in human myometrial cell lines to see the effects of 
overexpression of Hsf1 on factors such as cell proliferation and expression of target 
genes. 
Experiments utilized a pre-existing bank of frozen uterine tissue samples, tissue 
embedded in paraffin wax and tissue lysates collected by previous graduate students; 
Bryan White, Brandon Cross, Joy Williams and Mandy Peach. Additional samples were 
collected for this thesis when necessary to re-stock the bank, but all experimental work 
described in this thesis was performed by myself. 
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Chapter Two 
Materials and Methods 
2.1 Animals 
Sprague Dawley rats were acquired from the Mount Scio Vivarium (Memorial 
University of Newfoundland, St. John’s, NL, Canada). Rats were housed under standard 
environment conditions of 12 hour light and 12 hour darkness at the Animal Care Unit at 
the Health Sciences Centre, Memorial University of Newfoundland. Animals were 
provided water ad libitum and were fed LabDiet Prolab RMH 3000 (PMI Nutrition 
International, Brentwood, MO, USA). For all uterine studies, virgin female rats 
(approximately 220-250 g) were mated with stud male rats to induce pregnancy. 
Observation of a vaginal plug the morning following mating would mark day 1 of 
pregnancy, thus delivery was on day 23 under these standard conditions. All experiments 
were approved by the institutional animal care committee under protocols 08-02-DM to 
10-02-DM. 
 
2.2 Uterine Tissue Collection During Normal Pregnancy 
Individual non-pregnant or pregnant female rats were placed in a euthanasia 
chamber and exposed to an increasing concentration of carbon dioxide gas resulting in 
asphyxiation causing death within 5 minutes. For immunoblot analysis, the uterine horns 
were removed from the rat and opened longitudinally, exposing the fetuses and placentae, 
which were removed and discarded. The tissue was then placed on a chilled petri dish 
filled with phosphate-buffered saline (PBS) (pH = 7.4) where the endometrial layer was 
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scraped off with a scalpel blade (White et al., 2005). To store these samples, and to aid in 
their preservation, they were flash-frozen in liquid nitrogen and stored at -80 oC .  
For immunofluorescence detection, cross sectional portions of rat uterine horn 
were fixed in 4% paraformaldehyde (PFA) in PBS (pH 7.4) with shaking overnight at 
room temperature. Tissues were processed, paraffin embedded, sectioned and mounted 
on microscope slides by the Histology Unit of Memorial University of Newfoundland 
School of Medicine. All tissue sections utilized for experiments contained visible 
longitudinal and circular muscle layers of the myometrium. 
Each tissue set for both immunoblot and immunofluorescence studies were 
composed of samples from ten time points throughout gestation including: non-pregnant 
(NP), day 6, 12, 15, 17, 19, 21, 22, 23 (labour) and 1 day PP. Labour samples were 
collected after delivery of 2-3 pups when labour was still active. 
 
2.3 Experimental Design 
2.3.1 Unilateral Pregnancy Model 
Tissue samples from a unilateral pregnancy model were provided by Dr. Bryan 
White and specific details on the production of these samples can be found elsewhere 
(White & MacPhee, 2011). Briefly, virgin female rats were anaesthesized using a 1:1 
ratio of ketamine hydrochloride (ketaset) (Wyeth Animal Health, Guelph, Ontario) and 
xylazine (rompun) (Bayer HealthCare, Toronto, Ontario) per 100 grams weight. Once 
under general anaesthesia, a unilateral tubal ligation was performed through a flank 
incision. In doing so, this allowed pregnancy to occur in only one horn (Shynlova et al., 
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2007). Rats were given a 7-day recovery period, after which they were mated. 
Myometrial samples of the pregnant rat were collected on days 15 (n = 4), 19 (n = 4) and 
23 (labour; n = 8) of gestation from both non-gravid (empty) and gravid (stretched) 
uterine horns. Labour samples were collected after delivery of 2-3 pups when labour was 
still active.  
 
2.4 Immunoblot Analysis 
Immunoblot analysis was performed on samples obtained from normal pregnancy, 
a unilateral pregnancy model, or Human Telomerase Reverse Transcriptase- Human 
Myometrial cells (hTERT-HM) cell lysates (see section 2.6). Four independent sets of 
protein samples (n = 4 rats per gestational time point, n=4 different cell lysates) were 
used for all studies. Previously frozen rat myometrial samples were pulverized under 
liquid nitrogen and homogenized in radioimmunoprecipitation assay (RIPA) buffer (50 
mM Tris-HCL (pH 7.5), 150 mM NaCl, 1% (wt/vol) sodium deoxycholate, 1% (vol/vol) 
Triton X-100, and 0.1% (wt/vol) sodium dodecyl sulfate (SDS) containing phosphatase 
inhibitor cocktail and CompleteTM mini ethylenediaminetetraacetic acid (EDTA)-free 
protease inhibitors (Roche Molecular Biochemicals, Laval, Quebec, Canada) using a 
PreCellys Bead Mill. All samples were centrifuged at 15 000 x g at 4 oC  for 15 minutes, 
after which the supernatants were collected. A Bradford Assay (Bradford, 1976) using 
Bio-rad protein assay dye reagent (Bio-Rad Laboratories, Mississauga, Ontario, Canada) 
was used to determine the protein concentration of all protein lysates. The Bradford 
Method can determine the concentration of a protein sample by comparing the 
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spectrophotometric absorbance (A595 nm) of the sample to the absorbance of known 
standards (0, 2.5, 5, 10, 15, 20, 25 mg/ml bovine serum albumin (BSA) plotted on a 
standard curve.  Protein standards were prepared in duplicate, diluted in double deionized 
water (ddH2O) and the absorbance of the standards (A595) measured following addition of 
1mL 1X Bio-Rad protein assay dye reagent (Bio-Rad Laboratories, Mississauga, Ontario, 
Canada) using a Shimadzu BioMini spectrophotometer. A standard curve of A595 versus 
protein standard concentration was created using Microsoft Excel and used to determine 
the protein concentrations for each protein sample. To prepare each sample for the assay, 
1µL of each protein lysate was combined with 24µL of ddH2O and then 1mL of 1X Bio-
Rad protein assay dye reagent was added to each sample.  
 40 µg of each sample were separated by SDS-polyacrylamide gel electrophoresis 
(SDS-PAGE) in 12% resolving gels according to Laemmli (1970) and proteins were 
electroblotted to 0.2 µm nitrocellulose membranes (Thermo Scientific, Rockford, Illinois, 
USA). All subsequent antisera incubations and washes were performed with constant 
agitation on a shaker at room temperature. Membranes were washed for 5 minutes with 
Tris-buffered saline-Tween-20 (TBST; 20 mM Tris base, 137 mM NaCl, and 0.1% 
Tween-20; pH 7.6) followed by a 1 hour (h) block in 5% milk powder/TBST. Membranes 
were all probed with a primary antisera (Table 2.1) at the corresponding dilution for 2 
hours. Membranes then underwent 1 x 20min and 4 x 5min washes with TBST. Blots 
were then probed with the appropriate secondary antisera (Table 2.1) at the 
corresponding dilutions followed by 1 x 20min and 4 x 5min washes with TBST. A 
Pierce SuperSignal West Pico chemiluminescent substrate detection system (MJS  
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Table 2.1 Primary antisera utilized for experiments. Information provided includes the 
specificity of the antisera, the catalogue information and dilution with blocking solution. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Antisera) Method) Dilution) Company) Catalogue)#)
Heat%Shock%Factor%1%(Hsf1)% IB% 1:4000% Sigma%%MO,%USA% H%4163%
Heat%Shock%Factor%1%(Hsf1)% IF% 1:200% Sigma%%MO,%USA% H%4163%
pCHsf1%(Ser%230)CR% IB% 1:500% Santa%Cruz%CA,%USA% ScC30443CR%
Heat%Shock%Factor%1%AbC4%(Cones%4B4+%10H4+%10H8)% IB% 1:4000% Thermo%Scientific%CA,%USA% #RTC629CP0,%P1%or%CP%Hsf1,%pAB% IB% 1:4000% Enzo%Life%Sciences%PA,%USA% ADICSPAC901CD%
Mouse%monoclonal%(AC88)%to%HSP%90% IB% 1:2000% Abcam%MA,%USA% Ab13492%
Mouse%monoclonal%(AC88)%to%HSP%90% IB% 1:4000% Abcam%MA,%USA% Ab53497%
Hsp90% IB% 1:2000% StressMarq%BC.%Canada% SMCC107%A/B%
Hsf1%Antibody% IB% 1:1000% Cell%Signalling%ON,%Canada% #4356%
Heat%Shock%Factor%2%% IB% 1:%4000% Sigma%MO,%USA% H%6788%
Heat%Shock%Factor%2%% IF% 1:%500% Sigma%MO,%USA% H%6788%
Calponin% IB% 1:100%000% Sigma%MO,%USA% C2687%
AntiCMouse%IgG%(H+L)%HRP%Conjugate% IB% 1:10%000% Promega%WI,%USA% W402B%AntiCRabbit%IgG%(H+L)%Conjugate% IB% 1:10%000% Promega%WI,%USA% W401B%
AntiCRabbit%IgG%(whole%molecule)CFITC%antibody%% IF% 1:250% Sigma%MO,%USA% F7512%FITCCconjugated%Affinipure%Donkey%AntiCRabbit%IgG%(H+L)%
IF% 1:1000% Jackson%ImmunoResearch%PA,%USA% 711C095C152%TOCPRO®C3%Iodide%(642/661)% IF% 1:100% Invitrogen%NY,%USA% T3605%
PARPC1% IB% 1:2000% Invitrogen%NY,%USA% 436400%
Monoclonal%ANTICFLAG%M2% IB% 1:2000% Sigma%MO,%USA% F1804%
HspB8% IB% 1:1000% Lifespan%Biosciences,%WA,%USA% LSCC81990%HspB8% IB% 1:1000% Cell%Signalling,%ON,%CA% 3059%
Hsp70% IB% 1:1000% Enzo%Life%Sciences,%NY,%USA% ADICSPAC810%
Hsp%B1% IB% 1:1000% EMD%Millipore,%ON,%CA% 06C517%
%%IB=%Immunoblot%IF=%Immunofluorescence%%
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Biolynx, Inc., Brockville, Ontario, Canada) was used to detect protein expression. 
Several different blot exposure on Amersham enhanced chemiluminescence (ECL) film 
(GE Healthcare Limited, Little Chalfont, BKM, UK) were taken to ensure the exposure 
level of films were comparable between the sets and to ensure that the film response was 
in the linear range of detection. 
After probing the blots for the appropriate protein of interest, blots were then 
stripped for 45 minutes in RestoreTM Western Blot Stripping Buffer (Thermo Scientific, 
Rockford, IL, USA). Calponin protein expression was then measured as a normalization 
control for all blots. This protein is constitutively expressed in the rat myometrium in 
both pregnant and non-pregnant samples following RIPA lysis buffer protein extraction 
(White et al. 2005; Williams et al. 2005).  
 
2.5 Immunofluorescence 
Immunofluorescence detection was performed on samples obtained from normal 
pregnancy and unilateral pregnancy. All studies were repeated in triplicate with three 
independently collected samples (n=3). Slides containing tissue sections underwent 
several washes in xylene (3 X 100% for 5 min each), ethanol (1X 100%, 95%, 90%, 
80%, 70% and 50% for 3 min each) and finally PBS (3 X for 7 min each) in order to de-
wax and rehydrate the tissue sections. Two different types of epitope retrieval were then 
carried out in succession. First heat induced epitope retrieval using 0.01M sodium citrate 
buffer, pH 6.0 was performed. Slides were immersed for 10 minute periods in the 
solution that was preheated in a water bath at 95°C.  After the 10 minute immersion, 
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slides were transferred to a new preheated solution for another 10 minute period. This 
was repeated two additional times for a total of 40 minutes of immersion. Then, a second 
epitope retrieval was performed with a 15 minute incubation of tissue sections in 
1mg/mL trypsin in Tris buffer (4 mM CaCl2, 200 mM Tris, pH 7.7) at room temperature.   
Following epitope retrieval, tissue sections were then washed for 5 minutes in 
PBS followed by a 30 min block period with 5% normal goat serum/1% horse serum in 
PBS. Sections were then incubated overnight in a primary antisera, with shaking at 4 oC, 
or a non-immune IgG (negative control) of the same species as the primary antisera and 
utilized at the same concentration (Table 2.1). The next day, sections were washed in 
PBS (2 x 5min) and then incubated with the appropriate fluorescently-conjugated 
secondary antisera (Table 2.1) for 30 mins at room temperature with gentle agitation. 
Tissue sections examined by laser scanning confocal microscopy were also co-incubated 
with a TO-PRO®-3 nuclear stain (Invitrogen; T3605; 1:100) added to the secondary 
antisera solution. Sections were then washed with cold PBS containing 0.02% Tween-20 
(2 x 5 mins) and then mounted with Vectashield (Vector Laboratories Inc., Burlington, 
Ontario, Canada), containing 4’, 6-diamidino-2-phenylindole (DAPI) to stain nuclei. 
Either a Leica DMIRE2 microscope (Leica Microsystem (Canada) Inc., Richmond Hill, 
Ontario, Canada) equipped for epi-fluorescence  and with a QImaging Retiga EXi 
Camera (QImaging, Surrey, British Columbia, Canada) or a FluoView 300 laser scanning 
confocal microscope (Olympus Optical, Melville, NY) was used to examine the slides 
and capture images. Images collected on the Leica DMIRE2 microscope were analyzed 
using Improvision Openlab software version 5.5 (PerkinElmer, Waltham, MA, USA). 
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2.6 Cell Culture 
 Dr. Ann Word (Southwestern Medical Center; Dallas, Texas) graciously donated 
hTERT-HM cells, which were used for all cell experiments. This cell line has derived 
from human myometrial cells obtained from women who had undergone a hysterectomy. 
This cell line possesses several characteristics of endogenous uterine smooth muscle cells 
such as expression of the key markers calponin, oxytocin receptor, α smooth muscle 
actin, and the oxytocin receptor in addition to its maintained responsiveness to 17β-
estradiol. Also, hTERT-HM cells retain their elongated shape, central nucleus and their 
confluent sheet-like growth pattern. These similarities between the immortalized cell line 
and human myometrial smooth muscle cells make them an ideal model system to study 
myometrial development and function (Condon et al., 2002). 
 Dulbecco’s modified Eagle’s medium nutrient mixture F-12(Ham) 1X 
(DMEM/F12 1:1; Invitrogen, Burlington, ON, Canada) containing 10% fetal bovine 
serum (FBS; The Cell Culture Company, Oakville ON, Canada), 100U/ml penicillin and 
100µg/ml streptomycin (Invitrogen, Burlington, ON, Canada) was used for cell 
cultivation. Cells were grown in 75 cm2 flasks, in a 5% CO2 incubator maintained at a 
constant temperature of 37oC. Media was changed daily and cells grown until they 
reached approximately 80% confluency, after which they were either passaged into new 
75cm2 flasks to allow for further growth or they were used for various experiments. Cells 
were grown on 8 well chamber slides for immunofluorescence experiments and were 
grown on 6 well plates for transfection experiments. For immunofluorescence detection 
cells were seeded on chamber slides at approximately 10 000 cells per well and allowed 
 51 
to grow for 48 h at 37˚C. The cells were then fixed in 4% PFA/PBS for 
immunofluorescence (n=3).  
 
2.7 Plasmid Transformation 
DH5α competent cells (Invitrogen, Burlington, ON, Canada) were thawed on ice 
prior to transformation. 50µL of cells were transferred to a 15 mL Falcon tube pre-chilled 
on ice, to which 5µL of pCMV6 Hsf1 (Origene: MD,USA) plasmid was added. This 
mixture was then chilled on ice for 30 minutes, followed by a 90 second heat shock at 
42°C, and then re-chilled again for 2 minutes on ice. 1mL of pre-warmed cell culture 
media (without antibiotic) was then added to the mixture followed by shaking at 220rpm 
at 37°C for 1h. The mixture was then plated on pre-warmed agar plates with antibiotic 
(Kanamycin 25µg/mL), the plates inverted and incubated overnight at 37°C. Single 
colonies were then selected and added to 3mL of media with ampicillin in 15mL culture 
tubes. Cultures were left shaking overnight at 220 rpm at 37°C. 
 Plasmid DNA was isolated using a PureLink Quick Plasmid Miniprep Kit 
(Invitrogen, Burlington, ON, Canada) according to the manufacturer’s protocol and DNA 
concentration then measured using a NanoDrop Spectrophotometer. 
Samples were prepared for diagnostic restriction endonuclease digestion and 
agarose gel electrophoresis as follows; 1µg DNA, 10 µg/µL restriction enzyme, 1µL 10x 
buffer (chosen based on the restriction enzyme) and MilliQ water to make the solution up 
to 10µL. The mixtures were heated for 1h at 37°C in a water bath. The cDNA was 
inserted at the Sgfl/ Mlu I restriction sites of pCMV6 (Origene: MD,USA). This plasmid 
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was therefore verified using restriction enzymes Sgfl and Mlu I. Control restriction 
endonuclease digestions  (i.e. uncut plasmids) were made using 0.5 µg of DNA, buffer 
and water, but in the absence of restriction endonucleases. Before loading samples in the 
agarose gel, 1µL of 6X Dye was added to each sample. The 1% agarose gel that had been 
prestained with SYBR safe. Agarose gel electrophoresis was run for 40 minutes at 100V, 
after which digestions were then analyzed. 
Next a DNA GeneElute HP Plasmid Midiprep Kit (Sigma-Aldrich, MO, USA) 
was used to purify the plasmid DNA, according to manufacturer’s instructions. To 
alleviate any contamination with ethanol, a mixture of 0.1 volume of 3 M sodium acetate 
and 0.7 volume isopropanol was added to each sample. The samples were subsequently 
washed with 70% ethanol and then DNA was precipitated according to the midiprep kit 
(Sigma Aldrich). The precipitated DNA concentration was then determined using a 
NanoDrop spectrophotometer after resuspension in deionized water. After determining 
the sample concentrations, samples were prepared for agarose gel electrophoresis as 
escribed above. Samples were heated at 37oC for one hour, except for the uncut plasmids. 
Before loading samples onto the agarose gel 1µL of 6X Dye was added to each sample. 
Agarose gel was run for 40 minutes at 100V. The cDNA was inserted at restriction sites 
as described above.  
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2.8 Collection of cell protein lysates 
 For cell lysate preparation, these samples were rinsed in 5 mL of PBS, the PBS 
was aspirated, 0.5 mL of RIPA++ buffer was added to each flask, and flasks chilled on 
ice for 2-3 minutes until the containers were cool. Using a scraper, cells were scraped off 
the bottom of the dish and the mixture was placed into 1.5 mL microcentrifuge tubes. The 
samples were then centrifuged at 4°C for 15 minutes at 12 000 rpm. The supernatants 
were collected and placed in separate microcentrifuge tubes and stored at -80°C. 
 
2.9 Optimization of Transfection 
An Amaxa basic nucleofector kit for primary smooth muscle cells (Lonza, 
Mississauga, ON, Canada; Cat# VPI-1004) was used to determine which electroporation 
program would be optimal for transfection of hTERT-HM cells with the pmaxGFPTM 
expression vector provided. Cells were rinsed with 5 mL PBS and then incubated with 1 
mL trypsin for 5 minutes at 37°C to detach cells from the culture dish. One millilitre of 
media was then added to each flask to inactivate the trypsin. Each flask was repeatedly 
rinsed for ~2-3 minutes with the media/trypsin mixture using a serological pipet to ensure 
optimal cell detachment and disassociation into single cells. The mixture was then 
collected and pooled with solutions from other flasks in a 15mL tube. Cells were then 
counted using a hemacytometer and a volume of the solution containing approximately 1 
million cells was added to separate 15 mL tubes. Each tube was then centrifuged for 10 
minutes at 700 rpm. Excess media was aspirated and the pellet was then resuspended in 
100µL nucleofector solution (18 µL supplement + 82µL nucleofector solution). Then, 
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4µL of the pmaxGFPTM expression vector was added. The solution was then transferred 
to a cuvette and electroporation conducted using one of 6 programs (A-033, D-033, P-
013, P-042, U-025, B-017). Cell solutions that did not undergo electroporation served as 
controls. Then 0.5mL of media was added to each cuvette and the total solution was 
added to a 25cm3 flask containing 6mL of pre-warmed media. The flask was then 
incubated for 10 minutes at 37°C. After incubation, the media was equally distributed 
among 3 tissue culture wells of a 6-well plate so that each well contained 2mL of culture 
media. Cells were cultured for 72 hours and photographed every 24 hours to monitor the 
level of transfection and the amount of cell loss.  
 
2.10 Transfection of Cells 
 A myc-DDK-tagged pCMV6 Hsf1 expression vector (True-Orf, Rockville, MD; 
RC200314) was transfected into hTERT-HM cells, when cells reached ~80% confluency. 
An Amaxa basic nucleofector kit for primary smooth muscle cells (Lonza, Mississauga, 
ON, Canada; Cat# VPI-1004) was used for these experiments. Transfections were 
conducted as described in section 2.9 using program A-033. Three separate transfections 
were conducted, all using a total of 2 µg of plasmid DNA; the no program control (2µg 
the pmaxGFPTM expression vector), GFP (2 µg the pmaxGFPTM expression vector), 
and Myc-DDK-tagged Hsf1 (1 µg of pcMV6 Hsf1 expression vector and 1 µg pEGFP-C3 
expression vector). Cell solutions that did not undergo electroporation served as controls. 
Cells were cultured for 24-72 hours and photographed every 24 hours to monitor any 
observable changes resulting from the transfection.  
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 Co transfections were also performed using the same Hsf1 expression vector and 
a FLAG-tagged human pcMV7 PARP-1 vector (obtained from Dr. Girish Shah, Laval 
University, Quebec, Canada). Transfections were conducted as previously described 
above (Section 2.9). In these experiments four separate transfections were conducted, 
three of which used 2 µg of plasmid DNA; the no program control (2 µg pmaxGFPTM 
expression vector), GFP (2 µg pmaxGFPTM expression vector), and FLAG-tagged 
PARP-1 (1µg of pcMV7 PARP-1 expression vector and 1µg pmaxGFPTM expression 
vector). The final sample, the co transfected sample, contained both 1µg of pCMV-Hsf1 
and 1µg pCMV-PARP-1 and 0.5µg of pmaxGFPTM expression vector. Cells were 
cultured for 24-72 hours and photographed every 24 hours to monitor any observable 
changes resulting from the transfection. Once transfections were completed, either cell 
lysates were collected for protein analysis or a proliferation assay was performed. 
 
2.11 MTS Cell Proliferation Assay 
 The MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazolium) proliferation assay is used to measure the number of 
metabolically active cells remaining in a cell culture. The MTS is converted to soluble 
formazan by the dehydrogenase enzymes found in the metabolically active cells.  The 
quantity of the formazan product is then measured by an absorbance reading at 490 nm, 
and the magnitude of the reading is directly proportional to the number of living cells in 
culture. 
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2.11.1 Preparation of MTS and PMS Solutions 
 To prepare the MTS solution, 21 mL of Hank’s Balanced Salt Solution (HBSS), 
which contained no phenol, Mg+ or Ca2+, was added to a light protected container. 42 mg 
of MTS Reagent powder (Promega, Madison, WI, USA) was then added to the HBSS 
solution and mixed at moderate speed on a magnetic stir plate for ~ 15 minutes, or until 
the MTS was completely dissolved. The pH of the solution was then adjusted to be within 
the range of 6.0-6.5 using 1N HCl or 1N NaOH. The MTS solution was then filter 
sterilized through a 0.2 µm filter into a sterile 50 mL falcon tube. The soluntion was then 
aliquoted into 2mL volumes and stored at -20°C until needed. 
 To make the phenazine methosulfate (PMS) solution, 9.2 mg of PMS (Sigma, St. 
Louis, MO, USA) was added to a 15mL tube containing 10mL of 1X PBS and then 
mixed by inversion. The solution was then aliquoted into 200µL volumes and stored at -
20°C. 
 
2.11.2 Proliferation Assay 
 A mixture of PMS and MTS was made by adding 100µL of PMS solution to a 
2mL aliquot of MTS solution and mixed gently. Aliquots of 100µL were then added to 
each well of the 24 well plate containing hTERT-HM cells. The plate was then gently 
swirled to ensure a homogeneous media/MTS solution and was then returned to the 37°C 
incubator.  To measure the amount of soluble formazan produced by the cellular 
reduction of the MTS, an ELISA plate reader was used to record the absorbance at 
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490nm.  The absorbance readings were recorded at 30 minutes, 1 hour and 1.5 hour 
intervals.   
 
2.12 Data Analysis 
Densitometry on immunoblots was achieved using Scion Image Analysis software 
(Scion Image Corporation, Frederick, MD, USA). Densitometric values were normalized 
to the calponin loading control. GraphPad Instat version 3.0 (GraphPad Software, San 
Diego, CA, USA, www.graphpad.com) was used to carry out statistical analysis. Graphs 
were subsequently prepared using GraphPad Prism version 4.0 (GraphPad Software). All 
data from gestational profiles followed a Gaussian distribution as determined with a 
Brown-Forsythe test. Data from the gestational profile experiments were analyzed using a 
One-way analysis of variance (ANOVA) followed by Newman-Keuls post-hoc test. Data 
from unilateral pregnancy experiments were analyzed using a student t-test.  A 
comparison was considered statistically significant if it had a p-value < 0.05.  
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Chapter Three 
Results 
3.1 Normal Pregnancy and Labour 
3.1.1 Hsf1 Protein Expression Analysis 
 The expression of Hsf1 protein in the rat myometrium was studied using 
immunoblot analysis of both non pregnant (NP) and pregnant rat samples throughout the 
entire gestational period. Five complete independent sets of tissues were used for analysis 
(NP, d6, d12, d15, d17, d19, d21, d22, d23, PP).  To confirm equal loading of proteins in 
the immunoblots, following electroblotting of polyacrylamide gels, a MemCodeTM 
Reversible Protein Staining kit was used. 
The blots were probed with anti-rabbit Hsf1 specific antisera while anti-mouse 
calponin specific antisera was used to detect calponin as a normalization control. Both 
Hsf1 and calponin were detected at their predicted molecular weights of 75kDa and 
37kDa, respectively (Figure 3.1). The expression of total Hsf1 changed significantly 
throughout gestation (ANOVA p<0.05; n=5), being elevated in NP myometrium and 
highly expressed early in gestation at d6 and d12. Specifically, Hsf1 expression then 
significantly decreased at d15, d17, and d22 compared to d6 (p<0.05)..  
 
3.1.2 Immunofluorescent Detection of Hsf1 
 Immunofluorescence was used to detect the spatial arrangement of Hsf1 
throughout gestation. Analysis of both circular and longitudinal muscle layers  
demonstrated that throughout pregnancy total Hsf1 was primarily detected in the 
cytoplasm of myometrial cells (Figure 3.2-3.5) At all time points there was faint 
detection of Hsf1 in the cell nucleus, however this was minor compared to the amount  
  
 
 
 
 
Figure 3.1 Representative immunoblot and densitometric analysis of total Hsf1 protein 
expression in rat myometrial tissue throughout gestation. Both Hsf1 and calponin were 
detected at their appropriate molecular weights of 75kDa and 34kDa, respectively. 
Representative immunoblots are shown. Densitometric analysis of Hsf1 expression was 
performed. The histogram shown displays the relative optical density of Hsf1 
immunoblot data that has been normalized to the calponin loading control. Hsf1 
expression was found to change significantly across gestation (one-way ANOVA; 
p<0.05; n=5). The data are shown as mean ±S.E.M, and were from 5 different complete 
experiments. Data indicated with symbols were found to be statistically significant 
(p<0.05 d6 versus d15, d17, d 22). The Hsf1 expression was elevated early in pregnancy 
and then decreased suddenly and remained low until d23, labour (L). The decrease in 
expression from early gestation to late gestation was significantly different between d6 
and d15, d17 and d22. Defined abbreviations: NP= non-pregnant, PP= post-partum.   
 
 
 
 

  
 
 
 
 
 
Figure 3.2 Immunofluorescent detection of Hsf1 in rat uterine longitudinal muscle tissue 
from non pregnant rats to d17 of gestation. Cross sections of myometrial tissue were 
mounted onto slides and then probed with anti-rabbit Hsf1 specific antisera for 
immunofluorescence analysis. Throughout gestation the detection levels of Hsf1 did not 
change significantly. At all time points Hsf1 was mostly detected in the cytoplasm of 
cells, with very faint detection in the nuclei. Defined abbreviations: NP= non-pregnant, 
Ctrl= control, tissue section incubated with a matched IgG instead of antisera as a control 
for antisera specificity. Scale bar = 50µm. 
 
 
 
 
 
 
 
 

  
 
 
 
 
 
 
Figure 3.3 Immunofluorescent detection of Hsf1 in rat uterine longitudinal muscle tissue 
from d19 to post-partum. Cross sections of myometrial tissue were mounted onto slides 
and then probed with anti-rabbit Hsf1 specific antisera for immunofluorescence analysis. 
Throughout gestation the detection levels of Hsf1 did not change significantly. At all time 
points Hsf1 was mostly detected in the cytoplasm of cells, with faint detection in the 
nuclei. Defined abbreviations: PP= Post-partum, Ctrl= control. Scale bar = 50µm. 
 
 
 
 
 
 
 
 
 
 

  
 
 
 
 
 
 
 
 
 
Figure 3.4 Immunofluorescent detection of Hsf1 in rat uterine circular muscle tissue 
from non pregnant rats to d17 of gestation. Cross sections of myometrial tissue were 
mounted onto slides and then probed with anti-rabbit Hsf1 specific antisera for 
immunofluorescence analysis. Throughout gestation the detection levels of Hsf1 did not 
change significantly. At all time points Hsf1 was mostly detected in the cytoplasm of 
cells, with faint detection in the nuclei. Defined abbreviations: NP= non-pregnant, Ctrl= 
control, tissue section incubated with a matched IgG instead of antisera as a control for 
antisera specificity. Scale bar = 50µm. 
 
 
 
 
 
 
 
 

  
 
 
 
 
 
Figure 3.5 Immunofluorescent detection of Hsf1 in rat uterine circular muscle tissue 
from d19 to post partum.  Cross sections of myometrial tissue were mounted onto slides 
and then probed with anti-rabbit Hsf1 specific antisera for immunostaining. Throughout 
gestation the detection levels of Hsf1 did not change significantly. At all time points Hsf1 
was primarily detected in the cytoplasm of cells, with very faint detection in the nuclei. 
Defined abbreviations: NP= Post-partum, Ctrl= control. Scale bar = 50µm. 
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observed in the cytoplasm. Qualitatively, Hsf1 detection did not change markedly over 
the course of gestation. Furthermore, Hsf1 was also immunolocalized to the blood vessel 
SMCs and virtually undetectable in stromal fibroblasts around muscle bundles. 
To assess the quality of the Hsf1 antisera for immunofluorescence procedures, rat 
testis tissue sections were examined for localization of Hsf1 (Figure 3.6). Hsf1 protein 
expression was previously detected in rat testis, primarily in the cytoplasm by Akerfelt et. 
al (2010). Therefore, as a positive control, immunofluorescence was performed and 
confirmed that Hsf1 was localized to the cytoplasm of testicular cells. 
 
3.1.3 Immunofluorescent Detection of Hsf1 with Laser Scanning Confocal Microscopy 
To more specifically examine immunostained rat uterine tissue sections for Hsf1 
nuclear staining, 1µm thick optical sections of myometrial tissue were imaged by laser 
scanning confocal microscropy. Cross sections of myometrial tissue were immuno-
stained with an anti-rabbit Hsf1 specific antisera and TO-PRO®-3 nuclear stain. Hsf1 
was still mostly detectable in the cytoplasm; however it was also detectable as speckles in 
the nuclei of myometrial cells throughout gestation (Figure 3.7; n=3). 
 
3.2 Examination of pHsf1 (Ser 230) Expression 
3.2.1 Evidence for Post-translational Modifications 
 Hsf1 can undergo a wide variety of post-translational modifications (Hietakangas 
et al., 2006; Knauf et al., 1996). Thus, immunoblot analysis of Hsf1 expression was 
performed with both non pregnant and pregnant rat myometrium tissue lysates 
throughout the entire gestational period using 8% acrylamide gels, instead of 15%, to 
resolve potential changes in MW due to post-translational modifications. 
  
 
 
 
 
 
Figure 3.6 Verification of Hsf1 immunostaining with mouse testis.!Cross sections of 
mouse testis were probed with anti-rabbit Hsf1 specific antisera for immunofluorescence 
analysis. Hsf1 expression was detected in the rat testis, primarily in the cytoplasm of 
cells. This confirmed the appropriateness of the antiserum for immunofluorescence 
analysis. 
 
 
 
 
 
 
 
 
 
 
 
 
 

  
 
 
 
 
 
 
 
Figure 3.7 Spatial detection of total Hsf1 in rat uterine smooth muscle tissue throughout 
gestation using laser scanning confocal microscopy. Five gestational time points are 
shown as representative images for the entire pregnancy. Hsf1 was detected in cell nuclei 
as speckles throughout gestation. Images shown are representative of three different 
experiments. Scale bar = 100µm. NP= non-pregnant, Ctrl= control. 
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 The blot was probed with anti-rabbit Hsf1 specific antisera, and bands were 
detected in the ~60-75 kDa molecular weight range (Figure 3.8 A). The results indicated 
that myometrial Hsf1 may undergo a number of post-translational modifications which 
could account for the observed range in molecular weight. 
 
3.2.2 pHsf1 Protein Expression Analysis 
 Hsf1 can be actively phosphorylated (p) on the serine (ser)-230 residue leading to 
Hsf1 transcriptional activation (Knauf et al., 1996).  Thus, immunoblot analysis was 
performed with anti-rabbit pHsf1 (Ser-230) specific antisera using both non pregnant and 
pregnant rat myometrium tissue lysates to assess Hsf1 activation. pHsf1 was detected at a 
lower molecular weight than that of total Hsf1 (Figure 3.8 B). The expression of pHsf1 
changed throughout gestation, being elevated at NP and early in gestation at d6 and d12, 
then steadily decreasing from d15 onward. Specifically, there was a significant increase 
in pHsf1 expression at d12 compared to d22 (p<0.05).  
 
3.3 Unilateral Pregnancy Model 
3.3.1 Expression of Hsf1 protein 
 It was possible that uterine stretch, which increasingly occurs from mid-
pregnancy to term, might negatively regulate Hsf1 expression. A unilateral pregnancy 
model (Shynlova et al, 2007) was used to determine the effect of uterine stretch on Hsf1 
expression at d15, d19 and d23. Myometrial tissue lysates from both the gravid 
(stretched) and non-gravid (non-stretched) uterine horns were used for immunoblot 
analysis, and probed with anti-rabbit Hsf1 antisera (Figures 3.9, 3.10). There were no 
statistically significant changes in myometrial Hsf1 expression between the gravid and 
non-gravid horns at any time point (p>0.05).  
 
 
 
Figure 3.8 Hsf1 undergoes post-translational modification.  A) Total Hsf1 expression in 
rat myometrial tissue throughout gestation resolved using an 8% acrylamide gel. A 
representative immunoblot is shown. Several bands can be seen in the 60-75kDa range as 
Hsf1 undergoes several forms of post-translational modifications. Defined abbreviations: 
NP= non-pregnant, PP= post-partum.  B) Phosphorylated (Ser-230) Hsf1 expression in 
rat myometrial tissue throughout gestation. Both pHsf1 and calponin were detected at the 
molecular weights of ~60kDa and 34kDa, respectively. Representative immunoblots are 
shown. At 10 different gestational time points, densitometric analysis of pHsf1 was 
performed. The histogram shown displays the relative optical density of pHsf1 that has 
been normalized to the calponin loading control. pHsf1 expression was found to change 
significantly across gestation (one-way ANOVA; p<0.05; n=4). The data is shown as 
mean ±S.E.M, and came from 4 different experiments. Data indicated with symbols were 
found to be statistically different after post hoc statistical tests were performed (p<0.05 
d12 versus d22). The pHsf1 expression was elevated early in pregnancy and then 
decreased gradually until d23 labour (L). The data showed there was a significant 
increase in pHsf1 expression at d12 compared to d22. Defined abbreviations: NP= non-
pregnant, Cont= Contractile Phase, PP= post-partum.   
 
 
 
 
 
 
 
 
 
 
 
 

 
 
 
 
 
 
 
 
Figure 3.9  Representative immunoblot and densitometric analysis of Hsf1 at d15 and 
d19 in both gravid and non-gravid horns. Uterine stretch had no significant effect on total 
Hsf1 expression. There were no significant differences in myometrial Hsf1 expression 
between the gravid and non-gravid horn at d15 or d19 of gestation (d15 p=0.97 
D19 p=0.96). A) A representative immunoblot is shown that detected Hsf1 and calponin 
at d15 of pregnancy and at their respective molecular weights of 75kDa and 34kDa. The 
histogram shown displays the relative optical density of Hsf1 that has been normalized to 
the calponin loading control. The data are shown as mean ± S.E.M, and are from 4 
different experiments (n=4) at d15. B) A representative immunoblot is shown that 
detected Hsf1 and calponin at d19 of pregnancy. The histogram shown displays the 
relative optical density of Hsf1 that has been normalized to the calponin loading control. 
The data are shown as mean ± S.E.M, and are from 4 different experiments (n=4) at d19. 
Defined abbreviations: G= gravid (stretched), NG= non-gravid (non-stretched). 
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Figure 3.10 Representative immunoblot and densitometric analysis of Hsf1 at d23 in 
both gravid and non-gravid horns. Uterine stretch had no significant effect on total Hsf1 
expression. There were no significant differences in myometrial Hsf1 expression between 
the gravid and non-gravid horn at d23 of gestation.  A representative immunoblot is 
shown and the histogram displays the relative optical density of Hsf1 that has been 
normalized to the calponin loading control. The data are shown as mean ± S.E.M, and 
were from 4 different experiments (n=4) at d23. Defined abbreviations: G= gravid 
(stretched), NG= non-gravid (non-stretched). 
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3.3.2 Immunofluorescent Detection of Hsf1 
 Immunofluorescence was used to detect the spatial arrangement of Hsf1 in both 
gravid and non-gravid uterine tissue. Analysis of both circular and longitudinal muscle 
layers demonstrated that total Hsf1 was similarly detected in both gravid and non-gravid 
tissues and was primarily detected in the cytoplasm of myometrial cells (Figures 3.11, 
3.12). In all tissue sections there was faint detection of Hsf1 in the cell nucleus; however, 
this was minor compared to the amount observed in the cytoplasm. Furthermore, Hsf1 
was immunolocalized to blood vessel SMCs and virtually undetectable in stromal 
fibroblasts around muscle bundles. 
 
3.3.3 Expression of pHsf1 protein 
 Since pSer-230 Hsf1 is the transcriptionally active form of Hsf1, it was possible 
that uterine stretch might specifically regulate its expression. The same unilateral 
pregnancy model (Shynlova et al, 2007) was used to determine the effect of uterine 
stretch on pSer-230 Hsf1 expression at d15, d19 and d23. Myometrial tissue lysates of 
both the gravid (stretched) and non-gravid (non-stretched) uterine horns were used for 
immunoblot analysis and probed with anti-rabbit pSer-230 Hsf1 (Figures 3.13, 3.14). 
There were no statistically significant changes in pHsf1 expression between the gravid 
and non-gravid horns at any time point (p>0.05).  
 
3.4 Examination of Hsf2 Expression 
3.4.1 Hsf2 Protein Expression Analysis 
Hsf2 can form hetero-trimers with Hsf1 and it is involved in several 
developmental processes such as spermatogenesis (Akerfelt et al., 2007). Thus,  
 
  
 
 
 
 
 
 
 
Figure 3.11 Immunofluorescent detection of total Hsf1 in rat uterine longitudinal muscle 
tissue in both gravid and non gravid horns at d19 and d23 of gestation. Cross sections of 
myometrial tissue were mounted onto slides and then probed with anti-rabbit Hsf1 
specific antisera for immunofluorescence analysis. Hsf1 was robustly detectable in the 
cytoplasm of cells, with very faint detection in the nuclei at all timepoints. The detection 
levels of Hsf1 were also not altered. Defined abbreviations: Ctrl= control. Scale bar = 
50µm. 
 
 
 
 
 
 
 
 

  
 
 
 
 
 
 
 
Figure 3.12 Immunofluorescent detection of total Hsf1 in rat uterine circular muscle 
tissue in both gravid and non gravid horns at d19 and d23 of gestation. Cross sections of 
myometrial tissue were mounted onto slides and then probed with anti-rabbit Hsf1 
specific antisera for immunofluorescence analysis. Hsf1 was robustly detectable in the 
cytoplasm of cells, with very faint detection in the nuclei at all timepoints. The detection 
levels of Hsf1 were also not altered. Defined abbreviations: Ctrl= control. Scale bar = 
50µm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

 
 
 
 
 
 
 
 
Figure 3.13  Representative immunoblot and densitometric analysis of pSer-230 Hsf1 at 
d15 and d19 in both gravid and non-gravid horns. Uterine stretch had no significant effect 
on pSer-230 Hsf1 expression. At d15 and d19 of gestation there were no differences in 
Hsf1 expression between the gravid and non-gravid horn. A) Representative 
immunoblots are shown demonstrating detection of pSer-230 Hsf1 and calponin at d15 of 
pregnancy. The histogram below the immunoblots displays the relative optical density of 
Hsf1 that has been normalized to the calponin loading control. B) Representative 
immunoblots are shown demonstrating detection of Hsf1 and calponin at d19 of 
pregnancy. The histogram shown below the immunoblots displays the relative optical 
density of Hsf1 that has been normalized to the calponin loading control. All data shown 
in A) and B) represent means ± S.E.M and are from 4 different experiments (n=4) at each 
timepoint. Defined abbreviations: G= gravid (stretched), NG= non-gravid (non-
stretched). 
 
 
 
 
 
 
 

  
 
 
 
 
Figure 3.14  Representative immunoblot and densitometric analysis of pSer-230 Hsf1 at 
d23 in both gravid and non-gravid horns. Uterine stretch did not alter pSer-230 Hsf1 
expression at d23 of pregnancy. Representative immunoblots are shown for Hsf1 and 
calponin. The histogram shown below the blots displays the relative optical density of 
Hsf1 that has been normalized to the calponin loading control. The data are shown as 
mean ± S.E.M, and were from 4 different experiments (n=4). Defined abbreviations: G= 
gravid (stretched), NG= non-gravid (non-stretched). 
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immunoblot analysis of Hsf2 protein expression in both non pregnant and pregnant rat 
myometrium tissue lysates was performed.  
Blots were probed with anti-rabbit Hsf2 specific antisera and anti-mouse calponin 
specific antisera. Hsf2 was detected at ~75kDa as expected and appeared to be 
constitutively expressed (Figure 3.15). No significant changes in Hsf2 protein expression 
were noted throughout gestation (p>0.05). 
 
3.4.2 Immunofluorescent Detection of Hsf2 
 Immunofluorescence was used to detect the spatial expression of Hsf2 in 
myometrial cells throughout gestation. Analysis of both circular and longitudinal muscle 
layers demonstrated that throughout pregnancy total Hsf2 was primarily detected in the 
cytoplasm of myometrial cells and Hsf2 detection did not change markedly over the 
course of this period (Figures 3.16-3.19). 
 
3.5 Examination of PARP-1 Expression 
3.5.1 PARP-1 Protein Expression Analysis 
PARP-1 mediates nucleosome dissociation on target genes of Hsf1, allowing for 
their transcription (Petesch et al., 2008). It is also known to be involved in processes such 
as proliferation, differentiation and tumor cell transformation, which are similar to those 
of Hsf1 (Petesch et al., 2008). Knowing this, immunoblot analysis was performed to 
assess PARP-1 expression in both non pregnant and pregnant rat myometrium tissue 
lysates throughout the entire gestational period. 
Blots were probed with anti-mouse PARP-1 specific antisera and anti-mouse 
calponin specific antisera. PARP-1 was detected at 115kDa and expression showed a  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.15 Representative immunoblot and densitometric analysis of total Hsf2 protein 
expression. Representative immunoblots are shown and demonstrate detection of Hsf2 
and calponin at appropriate molecular weights. At 10 different gestational time points, 
densitometric analysis of Hsf2 immunoblots was performed. The histogram shown 
displays the relative optical density of Hsf2 that has been normalized to the calponin 
loading control. Hsf2 expression did not significantly change throughout gestation (one-
way ANOVA; p>0.05; n=4). The data are shown as mean ±S.E.M, and were from 4 
different experiments. Defined abbreviations: NP= non-pregnant, PP= post-partum, L= 
labour (d23).   
 
 
 
 
 
 
 
 
 

  
 
 
 
 
 
 
 
 
Figure 3.16 Immunofluorescent detection of total Hsf2 in rat uterine longitudinal muscle 
tissue from non pregnant rats to d17 of pregnancy. Cross sections of myometrial tissue 
were mounted onto slides and then probed with anti-rabbit Hsf2 specific antisera for 
immunofluorescence analysis. Throughout gestation the detection levels of Hsf2 did not 
change significantly. At all time points Hsf2 was detected in the cytoplasm of cells, with 
very faint detection in the nuclei. Defined abbreviations: NP= non-pregnant, Ctrl= 
control, tissue section incubated with a matched IgG instead of antisera as a control for 
antisera specificity. Scale bar = 50µm. 
 
 
 
 
 
 
 
 
 
 

  
 
 
 
 
 
 
 
 
Figure 3.17 Immunofluorescent detection of total Hsf2 in rat uterine longitudinal muscle 
tissue from d19 of pregnancy to post partum. Cross sections of myometrial tissue were 
mounted onto slides and then probed with anti-rabbit Hsf2 specific antisera for 
immunofluorescence analysis. Throughout gestation the detection levels of Hsf2 did not 
change significantly. At all time points Hsf2 was mostly detected in the cytoplasm of 
cells, with faint detection in the nuclei. Defined abbreviations: PP= Post-partum, Ctrl= 
control. Scale bar = 50µm. 
 
 
 
 
 
 
 
 
 

  
 
 
 
 
 
 
Figure 3.18 Immunofluorescent detection of total Hsf2 in rat uterine circular muscle 
tissue from non pregnant rats to d17 of pregnancy. Cross sections of myometrial tissue 
were mounted onto slides and then probed with anti-rabbit Hsf2 specific antisera for 
immunofluorescence analysis. Throughout gestation the detection levels of Hsf2 did not 
change significantly. At all time points Hsf2 was mostly detected in the cytoplasm of 
cells, with faint detection in the nuclei. Defined abbreviations: NP= non-pregnant, Ctrl= 
control, tissue section incubated with a matched IgG instead of antisera as a control for 
antisera specificity. Scale bar = 50µm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.19 Immunofluorescent detection of total Hsf2 in rat uterine circular muscle 
tissue from d19 of rat pregnancy to post-partum. Cross sections of myometrial tissue 
were mounted onto slides and then probed with anti-rabbit Hsf2 specific antisera for 
immunofluorescence analysis. Throughout gestation the detection levels of Hsf2 did not 
change significantly. At all time points Hsf2 was primarily detected in the cytoplasm of 
cells, with faint detection in the nuclei. Defined abbreviations: NP= Non= pregnant, L= 
Labour (d23), PP= Post-partum, Ctrl= control. Scale bar = 50µm. 
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significant decrease at d 12, 15, 17 and 19 when compared to NP, PP and d 6, 21, 22, and 
23 (Figure 3.20).  
 
3.6 Exogenous Expression of Hsf1 in hTERT-HM Cells 
3.6.1 Restriction Endonuclease Digestion of pCMV6-Hsf1 Vector 
 Before transient transfection of hTERT-HM cells with a pCMV6-Hsf1 vector 
could be performed, restriction endonuclease digestion was conducted to verify the 
identity of the purified pCMV6-Hsf1 expression vector. The cDNA was inserted into the 
AsiSI/ Mlu I restriction sites of pCMV6 (Origene: MD, USA) and was therefore verified 
using these restriction enzymes . The uncut plasmid displayed two bands following 
electrophoresis representing supercoiled and relaxed circular forms of DNA, respectively. 
Following digestion of the vector using AsiSI/Mlu1, two expected DNA bands were 
visible, with an expected size of ~1600 bp, representing the insert, and ~12 000 bp, 
representing the pcMV6 expression vector (Figure 3.21). The same restriction 
endonuclease digestions of the expression vector were performed following midi 
preparation of the vector and DNA purification.  
 
3.6.2 Optimization of Transfection Efficiency of hTERT-HM Cells 
hTERT-HM cells were transfected using an Amaxa Nucleofector system. Prior to 
any transfections, experiments were conducted in triplicate to optimize the transfection 
efficiency. An Amaxa basic nucleofector kit for primary smooth muscle cells (Lonza) 
was used to transiently transfect hTERT-HM cells with the pEGFP-C3 expression vector 
capable of expressing green fluorescent protein. Six different programs were tested for  
  
 
 
Figure 3.20 PARP-1 expression in rat myometrial tissue throughout gestation. A) Both 
PARP-1 and calponin were detected at the molecular weights of 115kDa and 34kDa, 
respectively. Representative immunoblots are shown that demonstrate their molecular 
weights. At 10 different gestational time points, densitometric analysis of PARP-1 was 
performed. The histogram shown displays the relative optical density of PARP-1 that has 
been normalized to the loading control, calponin, which accounts for any discrepancies, 
which may have occurred in loading the samples. PARP-1 expression was found to 
change significantly across gestation, following one-way ANOVA (p<0.05; n=4). The 
data is shown as mean ±S.E.M, and came from 4 different complete experiments. Data 
indicated with symbols were found to be statistically different after a post hoc Newman 
Keuls was performed (p<0.05). The PARP-1 expression was elevated early and late in 
pregnancy and then decreased in expression mid gestation. The data showed there was a 
significant decrease in expression at d12, 15, 17 and 19 when compared to all other time 
points throughout gestation. Defined abbreviations: NP= non-pregnant, PP= post-
partum.   
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Figure 3.21 Representative restriction endonuclease digestion of the pCMV6 expression 
vector encoding a Myc-DDK tagged human Hsf1 cDNA construct. PureLink Quick 
Plasmid Miniprep Kit was used for DNA plasmid purification. For each enzyme, the 
vector was digested at 37oC in a water bath for 1 hour and the product compared to uncut 
pCMV6 Hsf1 plasmid DNA. Digestions were run on a 1% agarose gel that was 
prestained with SYBR Safe DNA gel stain. Lane 1, 1kb DNA Ladder; lane 2, uncut 
pCMV6 Hsf1 vector sample 1; lane 3, DNA digestion using AsiSI/MluI; lane 4, DNA 
digestion using MluI; lanes 5, 6 and 7 are the same as lanes 2, 3 and 4 except for pCMV6 
Hsf1 vector sample 2 was used. Two bands are visible in the uncut plasmid lane since the 
circular DNA runs as two forms which migrate differently on a gel: a supercoiled and 
relaxed circular form. Digestion using both restriction enzymes was able to release the 
insert from the plasmid. Following digestion with only MluI, only one band was observed 
representing linearized plasmid DNA. 
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optimal transfection efficiency of the cells; A-033, D-033, P-013, P-042, U-025, B-017 or 
no program (control) and were examined at 24 and 48 hours (Figures 3.22, 3.23). This 
optimization of transfection was repeated with programs A-033 and U-025, which were 
the programs that showed the highest transfection efficiency and the lowest amount of 
cell loss. Consultation with Lonza also resulted in the testing of an additional program B-
017 at two different time-points of 24 and 48 hours (Figures 3.24, 3.25). A-033 appeared 
to have the highest transfection efficiency and the least amount of hTERT-HM cell loss, 
and therefore was utilized for all further transfection experiments.  
 
3.6.3 Transfection of hTERT-HM Cells with pCMV6-Hsf1 Vector 
  hTERT-HM cells were transiently co-transfected with a pCMV6-Hsf1 expression 
vector as well as a pEGFP-C3 expression vector to assess the effect of exogenous Hsf1 
expression on these myometrial cells. As controls, additional cells were transfected with a 
pEGFP-C3 expression vector alone or not transfected (No Program). Phase contrast and 
fluorescent images were taken 24 hours, 48 hours and 72 hours following transfection. A 
representative image is shown at 72 hours, which also reflects the results seen at 24 and 
48 hours. (Figure 3.26). 
 Protein lysates were also collected from hTERT-HM cells at both 24 and 72 hours 
post transfection with the pCMV6-Hsf1 expression vector. Immunoblot analysis was 
performed using a FLAG-tag specific antibody (Table 2.1) to recognize FLAG-tagged 
Hsf1 and confirm the transfection was successful. The analysis showed Hsf1 at ~75kDa 
only in cells transfected with pCMV6-Hsf1 (Figure 3.27 A). Immunoblot analysis was 
performed again with an Hsf1 specific antibody (Table 2.1) and this analysis detected  
  
 
 
 
 
 
 
Figure 3.22 Examination of optimal transfection efficiency of hTERT-HM cells with 
pEGFP-C3 vector 24 h post-transfection. Experiments were conducted to determine 
which electroporation program (A-033, D-033, P-013, P-024, U-025), would provide the 
highest percentage of transfected cells with the least amount of cell death in hTERT-HM 
cells. Experiments were conducted with a basic nucleofector kit for smooth muscle cells. 
Images in the left hand column represent phase contrast micrographs, and images on the 
right hand column represent immunofluorescence micrographs showing which cells have 
been transiently transfected with the pEGFP-C3 expression vector. Images were taken 24 
hours after transfection.  
 
 
 
 
 
 
 

  
 
 
 
 
 
 
Figure 3.23 Examination of optimal transfection efficiency of hTERT-HM cells with 
pEGFP-C3 vector 48 h post-transfection. Experiments were conducted to determine 
which electroporation program (A-033, D-033, P-013, P-024, U-025), would provide the 
highest percentage of transfected cells with the least amount of cell death in hTERT-HM 
cells. Experiments were conducted with a basic nucleofector kit for smooth muscle cells. 
Images in the left hand column represent phase contrast micrographs, and images on the 
right hand column represent immunofluorescence micrographs showing which cells have 
been transiently transfected with the pEGFP-C3 expression vector. Images were taken 48 
hours after transfection.  
 
 
 
 
 
 
 

  
 
 
 
 
 
 
Figure 3.24 Optimization of transfection efficiency of hTERT-HM cells with programs 
A-033, U-025, and B-017 24 h post-transfection. An experiment was conducted focusing 
on two previously used transfection programs, A-033 and U-025, which previously 
appeared to be optimal for hTERT-HM cells. A third program, B-017, was suggested by 
the Nucleofector Company Lonza, and thus examined as well. Images in the left hand 
column represent phase contrast micrographs, and images on the right hand column 
represent immunofluorescence micrographs showing which cells have been transiently 
transfected with the pEGFP-C3 expression vector. Images were taken 24 hours after 
transfection.  
 
 
 
 
 
 
 

  
 
 
 
 
 
Figure 3.25 Optimization of transfection efficiency of hTERT-HM cells with programs 
A-033, U-025, and B-017 48 h post-transfection. An experiment was conducted focusing 
on two previously used transfection programs, A-033 and U-025, which previously 
appeared to be optimal for hTERT-HM cells. A third program, B-017, was suggested by 
the Nucleofector Company Lonza, and thus examined as well. Images in the left hand 
column represent phase contrast micrographs, and images on the right hand column 
represent immunofluorescence micrographs showing which cells have been transiently 
transfected with the pEGFP-C3 expression vector. Images were taken 48 hours after 
transfection.  
 
 
 
 
 
 
 
 

  
 
 
 
 
 
Figure 3.26 Transient co-transfection of hTERT-HM cells with pCMV6-Hsf1 and 
pEGFP-C3.  hTERT-HM cells were either mixed with pEGFP-c3 expression vector but 
did not undergo electroporation (No program control), transfected with pEGFP-C3 alone 
(GFP), or co-transfected with pEGFP-C3 and pCMV6-Hsf1 mammalian expression 
vectors (Hsf1).  The pCMV6-Hsf1vector contained a myc-DDK-tagged human Hsf1 
cDNA. Program A-033 was used for all transfections and images were taken 72 hours 
after transfection. Scale bar = 100 µm 
 
 
 
 
 
 
 
 
 
 

  
 
 
 
 
Figure 3.27 Confirmation of FLAG-tagged Hsf1 protein expression in transfected 
hTERT-HM cells 72h post transfection. hTERT-HM cells were transiently transfected 
with FLAG (DDK)-tagged pCMV6-Hsf1.  To verify transfection, transfected cells were 
collected for protein extraction, SDS-PAGE, and electroblotting.  Immunoblots were 
probed with a mouse monoclonal FLAG specific antisera (A) or rabbit polyclonal Hsf1 
specific antisera (B) and subsequently a rabbit specific GAPDH antisera. The first lane 
represents a no program control where cells did not undergo transfection with pEGFP-C3 
expression vector. The second lane represents a GFP control, where cells were transiently 
transfected with pEGFP-C3 alone. The third lane represents cells that were transfected 
with both FLAG-tagged pCMV6-Hsf1 and pEGFP-C3.   
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endogenous Hsf1 at 75kDa in all cells. FLAG-tagged Hsf1 was also detected slightly 
above 75kDa in pCMV6-Hsf1 transfected cells both at 24 h (data not shown) and 72 h 
post transfection (Figure 3.27 B).  
 The same protein lysates collected at 24 and 72 hours post transfection were used 
in subsequent immunoblot analyses to assess whether exogenous expression of Hsf1 
caused an increase in Hsf1 target gene expression (Table 2.1). Exogenous expression of 
Hsf1 did not increase Hsp 70, HspB1, PARP or HspB8 protein expression in the 
myometrium at 24 hours (Hsp70 only) or 72 hours post-transfection (HspB1, PARP-1, 
HspB8) (Figure 3.28). 
 
3.6.4 Transfection of hTERT-HM Cells with pCMV6-Hsf1 and pCMV7-PARP-1 Vectors 
 hTERT-HM cells were transiently co-transfected with a pCMV7-PARP-1 and 
pEGFP-C3 expression vectors to assess the effect of exogenous PARP-1 expression in 
these myometrial cells. Finally, a co-transfection of pCMV6-Hsf1 and pCMV7-PARP-1 
expression vectors with pEGFP-C3 was performed in order to assess the effect of 
expressing both exogenous proteins on target protein expression. hTERT-HM cells that 
were not transfected (No Program) served as a negative control. Phase contrast and 
fluorescent images were taken 24 hours, 48 hours and 72 hours following transfection. A 
representative image is shown at 72 hours, which also reflects the results seen at 24 and 
48 hours. (Figure 3.29). 
 Twenty four and 72 hours post transfection of hTERT-HM cells, protein lysates 
were collected for subsequent immunoblot analyses. Blots were probed with a FLAG  
  
 
Figure 3.28 Examination of expression of Hsf-1 inducible gene products following Hsf1 
overexpression. Twenty four hours, or 72 hours post transfection, cells were lysed, 
protein extracted and SDS-PAGE and electroblotting completed. A) Hsp 70 protein 
expression in hTERT-HM cells 24h post transfection with FLAG-tagged pCMV6Hsf1. 
Immunoblots were probed with mouse monoclonal Hsp70 specific antisera and a rabbit 
polyclonal GAPDH specific antisera. B) HspB1 protein expression in hTERT-HM cells 
72h post transfection. Immunoblots were probed with a mouse monoclonal HspB1 
specific antisera and a rabbit polyclonal GAPDH specific antisera.. C) PARP-1 protein 
expression in hTERT-HM cells 72h post transfection. Immunoblots were probed with a 
mouse monoclonal PARP-1 specific antisera and a rabbit polyclonal GAPDH specific 
antisera.  D) HspB8 protein expression in hTERT-HM cells 72h post transfection. 
Immunoblots were probed with a rabbit polyclonal HspB8 specific antisera and a rabbit 
polyclonal GAPDH specific antisera.  In all blots, the first lane represents a no program 
control where cells did not undergo transfection after addition of pEGFP-C3 expression 
vector to the cells. The second lane represents a GFP control, where cells were transiently 
transfected with pEGFP-C3 alone. The third lane represents cells that were co-transfected 
with FLAG-tagged pCMV6Hsf1 and pEGFP-C3. In all cases, there appeared to be no 
increase in Hsp70, HspB1, PARP-1 or HspB8 protein expression upon over- expression 
of Hsf1 in hTERT-HM cells when compared to the GFP control (p>0.05, n=3).  
 
 

  
 
 
 
 
 
Figure 3.29 Assessment of transfection efficiency following PARP-1 and Hsf1 
overexpression. Representative images from phase contrast micrographs and wide-field 
epi-fluorescence detection of hTERT-HM cells after co-transfection with mammalian 
expression vectors encoding hHsf1, hPARP-1, and EGFP cDNA. hTERT-HM cells were 
either mixed with mammalian expression vectors but did not undergo electroporation (No 
program control), transfected with pEGFP-C3 alone (GFP), co-transfected with pEGFP-
C3 and pCMV7- PARP-1 (pCMV7-PARP-1/GFP) or co-transfected with pEGFP-C3, 
pCMV7- PARP-1 and pCMV6-Hsf1 mammalian expression vectors (pCMV7-PARP-
1/pCMV6-Hsf1/GFP).  Images were taken 72h hours after transfection but similar results 
were also observed at 24h and 48 h (data not shown). Scale bar = 100 µm. 
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specific antisera and confirmed the expression of both FLAG-tagged Hsf1 and FLAG-
tagged PARP-1 at 24 hours (Table 2.1; Figure 3.30). Similar results were also seen at 72 
hours. Subsequent immunoblot analysis was also performed using Hsf1 or PARP-1 
specific antisera (Table 2.1). Endogenous Hsf1 and PARP-1 proteins were again detected 
in all lanes at their expected molecular weights of 75kDa and 115kDa, respectively. In 
the lanes where cells expressed exogenous levels of Hsf1, a band slightly higher than 
75kDa was observed, representing the FLAG-tagged form of the Hsf1 protein (Figure 
3.31). A similar doublet was not as resolvable for PARP-1 due to the higher molecular 
weight of PARP-1 and the percentage of acrylamide gel used for electrophoresis. 
 The same protein lysates collected at 24 and 72 hours post transfection were used 
in subsequent immunoblot analyses to determine whether exogenous co-expression of 
Hsf1 and PARP-1 resulted in an increase in target gene expression (Table 2.1). Results 
showed that exogenous co-expression of Hsf1 and PARP-1 did not increase Hsp70, 
Hsp90 or HspB1 expression in the myometrium (Figures 3.32). 
 
3.6.5 Assessment of Proliferation Post Transfection with pCMV6-Hsf1 and pCMV7-
PARP-1 Expression Vectors 
hTERT-HM cells were grown as previously described in section 2.6.  Cells were 
then transfected with pCMV6-Hsf1, pCMV7-PARP-1 or both expression vectors. Since 
both Hsf1 and PARP-1 are involved in cell proliferation, it was expected that cell 
proliferation would increase in hTERT-HM cells post transfection with these vectors. 
Following an MTS proliferation assay, it was demonstrated that cell proliferation (shown 
as percent cell survival) only significantly increased in hTERT-HM cells transfected with  
  
 
 
 
 
 
Figure 3.30 Confirmation of FLAG-tagged PARP-1 and Hsf1 protein expression in 
hTERT-HM cells 24h post transfection. hTERT-HM cells were transiently transfected 
with FLAG (DDK)-tagged pCMV6-Hsf1 and FLAG-tagged pcMV7PARP-1.  To verify 
transfection, transfected cells were collected for protein extraction, SDS-PAGE, and 
electroblotting.  Immunoblots were probed with a mouse monoclonal FLAG specific 
antisera and subsequently a rabbit specific GAPDH antisera. Bands were detected at 
~75kDa, ~115kDa and 37kDa, respectively, representing the FLAG-tagged Hsf1, FLAG-
tagged PARP-1 and the GAPDH control. The first lane represents a no program control 
where cells did not undergo transfection with pEGFP-C3 expression vector. The second 
lane represents a GFP control, where cells were transiently transfected with pEGFP-C3 
alone. The third lane represents cells that were transfected with both FLAG-tagged 
pCMV7-PARP-1 and pEGFP-C3. The final lane represents those cells that were co-
transfected with FLAG-tagged pCMV7-PARP-1 and FLAG-tagged pCMV6-Hsf1. 
 
 
 
 
 

  
Figure 3.31 Confirmation of Hsf1 and PARP-1 overexpression in transfected hTERT-
HM cells. A) Hsf1 protein expression in hTERT-HM cells 24 h post co-transfection. 
hTERT-HM cells were transiently transfected with pEGFP-C3 alone, FLAG-tagged 
pCMV7-PARP-1 alone, or FLAG-tagged pCMV6-Hsf1 and FLAG-tagged pCMV7-
PARP-1.  To verify transfection, transfected cells were collected for protein extraction, 
SDS-PAGE, and electroblotting.  Immunoblots were probed with a rabbit polyclonal 
Hsf1 specific antisera and subsequently a rabbit polyclonal GAPDH specific 
antisera.  Bands were detected in all lanes at 75kDa and 37kDa, respectively, representing 
the Hsf1 and the GAPDH control. In the fourth lane, a second band at a slightly higher 
molecular weight was observed, which represents the FLAG-tagged form of Hsf1. The 
first lane represents a no program control where cells did not undergo transfection after 
addition of mammalian expression vectors to the cells. B) PARP-1 protein expression in 
hTERT-HM cells 24 h post co-transfection. hTERT-HM cells were transiently 
transfected and cell lysates and immunoblots prepared as described above.  Immunoblots 
were probed with a mouse monoclonal PARP-1 specific antisera and subsequently a 
rabbit polyclonal GAPDH specific antisera.  Bands were detected in all lanes at 115kDa 
and 37kDa representing PARP-1 and GAPDH, respectively. In the fourth lane, a second 
band, representig the FLAG-tagged form of PARP-1, was not observed. This was 
expected since the endogenous and Flag tagged PARP-1 were difficult to resolve within 
the SDS-PAGE utilized. The first lane represents a no program control where cells did 
not undergo transfection after the expression vectors were added to cells.  
 

  
Figure 3.32 Examination of expression of Hsf-1 inducible gene products following Hsf1 
and PARP-1 overexpression.  A) Hsp70 protein expression in hTERT-HM cells 24 h post 
co-transfection. hTERT-HM cells were transiently transfected with pEGFP-C3, FLAG-
tagged pCMV7-PARP-1, or both FLAG-tagged pCMV6-Hsf1 and FLAG-tagged 
pCMV7-PARP-1. Immunoblots were probed with an mouse monoclonal Hsp70 specific 
antisera and then a rabbit polyclonal GAPDH specific antisera.  B) Hsp90 protein 
expression in hTERT-HM cells 24 h post co-transfection. hTERT-HM cells were 
transiently transfected as described above. Immunoblots were probed with an mouse 
monoclonal Hsp90 specific antisera and a then a rabbit polyclonal GAPDH specific 
antisera.  C) HspB1 protein expression in hTERT-HM cells 24 h post co-transfection. 
hTERT-HM cells were transiently transfected as described above.  Immunoblots were 
probed with an mouse monoclonal HspB1 specific antisera and then a GAPDH specific 
antisera. In all blots, the first lane represents a no program control where cells did not 
undergo transfection following addition of expression vectors to the cells. The second 
lane represents a GFP control, where cells were transiently transfected with pEGFP-C3. 
The third lane represents cells that were transfected with both FLAG-tagged pCMV7-
PARP-1 and pEGFP-C3. The final lane represents those cells that were co-transfected 
with FLAG-tagged pCMV7-PARP-1 and FLAG-tagged pCMV6-Hsf1. There appeared to 
be no increase in Hsp70, Hsp90, or HspB1 protein expression following exogenous 
expression of PARP-1 or PARP-1/Hsf1 in cells when compared to the GFP control. 
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pCMV7-PARP-1 or following co-transfection of pCMV6-Hsf1 and pCMV7-PARP-1 
(Figure 3.33). The results indicate a role for PARP-1 in regulating cell proliferation, but 
not Hsf1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
Figure 3.33 Assessment of proliferation following transfection with pcMV6-Hsf1 and 
pCMV7-PARP-1 expression vectors. hTERT-HM cells were transfected with pEGFP-C3 
alone, pCMV6-Hsf1 alone, pcMV7PARP-1 alone or co-transfected with both pCMV6-
Hsf1 and pcMV7PARP-1 expression vectors. Following an MTS proliferation assay, it 
was shown that cell proliferation (shown as percent cell survival) did significantly 
increase post transfection with pcMV7-PARP-1 and following co-transfection when 
compared to the GFP control (p<0.05). 
 !
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Chapter 4 
Discussion 
4.1 Expression of Hsf1 during Normal Pregnancy and Labour 
Little information is known about Hsf1 in the myometrium, as only one other 
paper has studied Hsf1 expression in the uterus. Stephens et al. (2010) conducted a 
proteomic study examining altered Hsf1 abundance in human eutopic endometrium of 
endometriosis patients in the mid-secretory phase of the menstrual cycle; however, this 
paper only stated that it was found in the uterus and nothing about Hsf1 expression or 
potential function. This research was also conducted in the endometrium, and in human 
subjects; therefore, the results presented in this thesis provide novel data on the 
expression of Hsf1 in uterus smooth muscle or myometrium. It was hypothesized that 
Hsf1 would be expressed in the myometrium during pregnancy and that it could be 
important during the proliferative phase of myometrial differentiation to activate 
expression of key genes necessary for this process.  
Expression of total Hsf1 protein was most elevated before pregnancy (NP) and up 
until d12 of gestation.  The expression was highest at d6 and then showed a significant 
decrease (p<0.05) in expression at d15, d17 and d22. This pattern supports our initial 
hypothesis that Hsf1 could contribute to the proliferation of myocytes, which occurs early 
in gestation. In contrast, immunofluorescence studies showed that Hsf1 was robustly 
detected throughout gestation, primarily in the cytoplasm of myometrial cells, with 
detection also in speckles within nuclei.  Although the pattern of expression seen in 
immunoblot analysis did not correlate with immunofluorescence detection, this may be 
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attributed to the fact that immunofluorescence is a less sensitive technique for 
quantification than immunoblot analysis and may not have been able to detect the 
fluctuations in expression. The presence of Hsf1 in the nucleus was confirmed by 
confocal analysis that showed there was a speckled appearance of Hsf1 detection in the 
nucleus. Hsf1 normally shuttles between the nucleus and cytoplasm (Yang et al., 2008), 
and our immunofluorescence detection of Hsf1 primarily in the cytoplasm of myometrial 
cells, and a lesser extent in cell nuclei agrees with the published literature (Anckar & 
Sistonen, 2007). The data also indicate that Hsf1 is available in myometrial cells to drive 
expression of key genes such as stress proteins. 
Detection of the active, phosphorylated (pSer-230) form of Hsf1 was also 
elevated early in pregnancy and subsequently decreased until PP.  In comparison to the 
immunoblot analysis of total Hsf1, active Hsf1 expression decreased more gradually. A 
pHsf1 to total Hsf1 ratiometric analysis was not completed as it is an insensitive and 
inappropriate comparison (Janes, 2015). According to Janes (2015), comparing two 
different antibodies with different affinities for total and phosphorylated Hsf1 is not an 
accurate evaluation of the amount of total protein to phosphorylated protein. The 
expression of pSer-230 was highest at d12 and was found to be significantly lower at d22 
when compared to d12 (p<0.05). Of note, the pSer230 Hsf1 band of interest was detected 
at a lower molecular weight than the total Hsf1 form. This may be attributed to the fact 
that in the literature, Hsf1 has been found to have a molecular weight range of about 60-
75kDa, and can appear on immunoblots as a large smear (Chou et al., 2012). This was 
also shown in figure 3.8 A. Hsf1 can undergo other post-translational modifications such 
as sumoylation and acetylation altering the observed molecular weight (Knauf et al., 
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1996; Chou et al., 2012). Therefore, it is possible that pHsf1 could be detected at a lower 
molecular weight than the total form of Hsf1.  
 The expression of Hsf1 and pHsf1 protein in the uterus by immunoblot analysis 
supported our initial hypothesis that Hsf1 could be involved in myocyte proliferation. It 
has already been well established by Shynlova and colleagues (2006) that myocyte 
proliferation peaks in this time frame when they detected an increased incorporation of 
5-bromo-2’-deoxyuridine incorporation, a well-known indicator of proliferation, in 
uterine myocytes during the early phase of pregnancy. Furthermore, several cancer 
studies have shown a relationship between Hsf1 and tumour cell proliferation (Dai et al., 
2007; Santagata et al., 2011). In breast cancer and skin cancer models, Hsf1 is able 
permit cancer cells to cope with various stressors, allowing tumour cells to reconfigure 
their metabolism, physiology, and protein homeostasis. If this adaptation to stress allows 
tumour cells to proliferate, then perhaps a similar mechanism occurs in the myometrium 
during early gestation. During this phase, several endocrine signals, such as 17β- 
Estradiol and the IGF, become abundantly present in the uterus to promote proliferation 
(Le Roith, 2003; Yin et al., 2007). This, coupled with embryonic implantation and other 
hormonal cues could create a stressful environment for developing myocytes. Therefore, 
it is possible that Hsf1 could be present to initiate the HSR, allow the uterine cells to 
proliferate, and to cope with these new stressors. 
 
4.2 The Effect of Distension on Hsf1 Expression 
 Uterine stretch in the rat, as a result of growing fetuses, is known to contribute to 
induction of labour at the end of gestation, and therefore places the uterus under a huge 
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amount of stress (Shynlova et al., 2010). Since Hsf1 is known to regulate the HSR under 
different physiological stresses, it was hypothesized that perhaps Hsf1 protein expression 
may be influenced by distension, mechanical stress, in the uterus during pregnancy. A 
unilateral tubal ligation was performed on virgin female rats, so that they were only able 
to become pregnant in one horn. This model is useful for researchers to observe the effect 
of distension on gene expression, while both horns (gravid and non-gravid) are still 
exposed to the relatively same endocrinological environment; however, it is important to 
note that the gravid horn will be exposed to paracrine factors produced by the 
surrounding fetal membranes and tissues during conception unlike the non-gravid horn 
(Ou et al., 2007).   
The levels of Hsf1 and pSer-230 Hsf1 protein expression were analyzed between 
the two horns to see if Hsf1 expression was influenced by stretch-induced stress at d15, 
d19 and d23 at which point mechanical stretch on the uterus should be maximal. There 
was no significant change in Hsf1 or pSer-230 Hsf1 protein expression between the 
stretched (gravid) and the non-stretched (non-gravid) horn, indicating Hsf1 may not be 
involved in stretch-induced gene expression in the myometrium. Only one other study 
has looked at the relationship between stretch and Hsf1 protein expression. Li et al. 
(2013) looked at the protein expression of Hsf1 in both stretched and non-stretched 
coronary artery fibroblasts in a mechanical stretch model. Through polymerase chain 
reaction (PCR) and Western Blot analysis, they did find a positive correlation between 
mechanical stretch and Hsf1 mRNA and protein expression. Although this relationship 
between Hsf1 protein expression and stretch was not supported by our data, it should be 
noted that this was an in vitro model of coronary artery perforation where our stretch 
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studies were completed in vivo. Also, Hsf1 is ubiquitously expressed in tissues, and 
therefore it is possible that it behaves differently in different cell types. It should also be 
noted that this study was only tested at three time points, d15, d19 and d23. It is possible 
that the correlation between stretch and Hsf1 may have occurred earlier in gestation, such 
as d6 when we know Hsf1 protein expression is high. Although stretch would not be as 
prominent at this time point, it is still present as the fetuses are growing rapidly at this 
time point as well. Our data is a novel study reflecting Hsf1 expression in both gravid and 
non-gravid myometrial tissue, and therefore further research is needed in this area. 
 
4.3 Expression of Hsf1 Associated Proteins in the Myometrium During Gestation 
 Several proteins have been shown to associate with Hsf1 in order to promote its 
transcriptional activity such as PARP-1 and Hsf2 (Anckar & Sistonen, 2007; Petesch et 
al., 2008). The expression of these two proteins, in particular, has yet to be shown in the 
myometrium, and therefore protein expression analysis was performed in order to begin 
investigating their potential role during pregnancy. 
Although PARP-1 has been historically known for its role in cell death, in more 
recent years its role in transcriptional activation has been well documented  (Ziegler & 
Oei, 2001; Chiarugi, 2002; Kraus & Lis, 2003). The association between Hsf1 and 
PARP-1 (described in further detail in section 1.9) leads to the initial round of 
nucleosome displacement so that transcription of the target gene can occur. PARP-1 was 
detected in the rat myometrium with a pattern of expression similar to Hsf1. It was 
robustly expressed early in gestation, decreased in mid gestation (during the synthetic 
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phase) followed again by increased expression until labour. Specifically, PARP-1 
expression was significantly expressed at NP, d6, d21, d22, d23 and PP when compared 
to all other time points examined. 
When DNA damage occurs, PARP-1 can positively contribute to the survival or 
proliferating cells. It uses NAD+ to synthesize a linear or multi-branched polymer of 
ADP- ribose on various nuclear protein acceptors usually associated with chromatin, or, 
itself in an auto-modification reaction. This modification of acceptors is what also helps 
with cell survival during times of stress (Amé et al., 2004). Up until approximately d14, 
myocytes are rapidly proliferating. This phase of hyperplasia is likely to cause some level 
of stress on myometrial cells, and with rapid cell proliferation, damage may occur. 
Therefore, PARP-1 expression early in gestation may be attributed to a potential role in 
repairing damaged myometrial cells. 
The observed pattern of PARP-1 protein expression in the myometrium may also 
be related to its known role in apoptosis (Elkholi & Chuphuk, 2014). During the synthetic 
phase (~d14) there is significant up-regulation of specific caspases, such as initiator 
caspase-9 and effector caspases 3, 6 and 7, which are essential for apoptosis (Shynlova et 
al., 2006).  These caspases have been shown to cleave PARP-1 in order to initiate the 
apoptotic pathway (Kaufmann et al., 1993).  The antibody used in the experiments 
described in this thesis detected the non-cleaved form of PARP-1 and during the 
synthetic phase, when several apoptotic machinery proteins become activated, non-
cleaved PARP-1 expression was much lower. These findings also support the possibility 
that PARP-1 could be involved in apoptosis during the synthetic phase of rat gestation. 
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It has been previously demonstrated that although Hsf2 does not respond to acute 
stress stimuli, like heat shock, it is constitutively active in mouse embryonic carcinoma 
cells, the blastocyst stage during mouse embryogenesis and during spermatogenesis 
(Mezger et al., 1994; Murphy et al., 1994; Sarge et al., 1994). This suggests that Hsf2 is a 
heat shock protein regulator during both differentiation and developmental processes by 
binding to HSEs of developmentally critical target genes (Yamamoto et al., 2009). 
Throughout pregnancy, the uterus undergoes several phases of differentiation (Shynlova 
et al., 2009). Therefore, it is possible, based on the constitutive Hsf2 protein expression 
pattern observed by both immunofluorescence and immunoblot analysis, that Hsf2 has a 
more developmental role in the uterus instead of a stress-mediated response (Leppa et al., 
1997).   
4.4 Expression of Hsf1 and Target Proteins in vitro. 
Hsf1 will bind to HSEs in the promoter region of a variety of stress and 
developmentally related genes. Some examples of these HSE containing genes are 
Hsp70, Hsp90 and HspB1 (Holbrook & Udelsman, 1994; Heldens et al., 2012; Neckers 
& Workman, 2012).  Previous research in our lab has demonstrated that some target 
genes of Hsf1 are in fact induced in the myometrium late in pregnancy and therefore 
could be regulated by Hsf1. White et al. (2005) showed that HspB1 mRNA and protein 
expression were upregulated from d15 of gestation and onwards, a time period directly 
following the observed increased expression of pSer-230 Hsf1. Evidence from our 
laboratory has also indicated that Hsp70 protein expression is upregulated late in 
gestation (Marsh et al., in preparation). Since these proteins are highly expressed during 
the synthetic and contractile phases of differentiation, when the uterus experiences 
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considerable stress from hypertrophic growth, changes in the cytoskeletal organization 
and cell-ECM contacts, it is possible that Hsf1 induces the expression of these target 
genes early in gestation to act as a coping mechanism to aid with changes in the uterus at 
later periods.  
Through in vitro experiments using a human myometrial cell line, exogenous 
Hsf1 was transiently expressed in hTERT-HM cells to see if this could influence the 
expression of target genes such as HspB1 and Hsp70. After collection of cell lysates 24 
and 72 hours post transfection, immunoblot analysis showed that none of the target genes 
were affected by expressing exogenous Hsf1. Co- expression of Hsf1 and PARP-1 was 
also performed, in the event that both proteins were required for gene upregulation; 
however, similar results were observed. 
Hsf1 or Hsf1 and PARP-1 co-expression did not induce target gene expression, 
but this could be due to potential limitations of using transient transfections to induce 
gene/protein expression. One major difficulty with transiently expressing proteins is that 
it produces a large population of heterogeneous cells. These cells not only contain highly 
variable amounts of the target proteins, but frequently manifest disruptions in cycling and 
growth properties (Walker et al., 1999). Furthermore, Hsf1 binds to genes in order to 
upregulate mRNA expression followed by expression of proteins. Therefore, it may have 
been more appropriate to look at the resulting mRNA levels of target genes rather than 
protein expression alone. Finally, the HSR is often a quick response in most cases. In 
fact, rapid induction of Hsp70 gene expression in response to cellular stresses, including 
heat shock, can occur in just minutes (Boehm et al., 2003; Yao et al., 2006). It is possible 
that the 24 and 72 hour time points examined for Hsf1 induced gene expression were 
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inappropriate. Perhaps a more effective time point would have been only minutes post-
transfection. Based on the current finding and the available data in the literature it is 
unclear whether or not Hsf1 or Hsf1 and PARP-1 can influence Hsp70 and HspB1 
expression in a myometrial cell line.  
 
4.5 The role of Hsf1 in Myocyte Proliferation 
Since Hsf1 is upregulated early in gestation, it may be important in inducing Hsp 
mRNA levels early in gestation to create a pool of stress proteins. This abundance of 
stress proteins would then be readily available later in pregnancy. Hsf1 also upregulates 
proteins not involved in stress, such as those involved in development and differentiation 
(Jedlicka et al., 1997). Therefore, it is possible that Hsf1 also upregulates proteins 
involved in myometrial proliferation and differentiation early in pregnancy which 
decreases afterwards once they are no longer needed. Jedlicka et al., (1997) demonstrated 
that Hsf1 is involved in Drosophila larval development and oogenesis, mediating 
processes like cell growth, chromosomal endoreplication and cell proliferation and 
differentiation. Therefore, perhaps in utero, Hsf1 could increase myocyte proliferation.   
To test this hypothesis, hTERT-HM cells were transiently transfected with Hsf1 
or PARP-1 or co-transfected with both Hsf1 and PARP-1 and then any changes in 
myometrial cell proliferation assayed as a result of increased exogenous levels of these 
proteins. Cells transfected with PARP-1 and Hsf1/PARP-1 exhibited significantly higher 
proliferation than the control cells. This result indicated that it is most likely PARP-1 and 
not Hsf1 that can induce proliferation in myometrial cells grown in vitro.  
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4.6 Future Directions 
This current work provides much needed insight into the expression and potential 
role of Hsf1 and associated proteins in the myometrium throughout gestation. As little 
information was known about Hsf1 in the uterus at all, this novel study will help provide 
a better knowledge of the potential factors affecting myometrial development. The 
pattern of expression of Hsf1, pSer-230 Hsf1, Hsf2, and PARP-1 indicate that these 
factors could play a role in regulating myometrial differentiation during early pregnancy, 
but only PARP-1 appears to regulate myometrial proliferation in myometrial cells in 
vitro. Despite all of this new knowledge, there are several more avenues that should be 
explored to study Hsf1 and the myometrium. 
First of all, additional studies should be performed to determine the targets for 
Hsf1-induced transcription. Using the tissue samples collected throughout rat gestation 
and the hTERT-HM cell lysates, a chromatin immunoprecipitation (ChIP) assay could be 
performed with Hsf1-specific antisera to see exactly what genes it interacts with. 
Specifically, a cross-linked ChIP (XChIP) could be performed. Once the DNA is sheared 
in the initial steps of the XChIP, an antibody specific to Hsf1 could be used, since Hsf1 
binds directly to the DNA. Then the DNA associated with Hsf1 could be purified and 
identified using a PCR or direct high-throughput sequencing. Through this assay, it could 
be determined if in fact Hsf1 interacts with specific Hsp genes, including those studied in 
our lab, or if it interacts with other factors that could be involved in proliferation and 
subsequently studied. 
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Although it was shown through confocal microscopy that Hsf1 was detectable as 
speckles in the nuclei of uterine myometrial cells throughout gestation, further 
investigations that show Hsf1 is truly a nuclear protein should be performed. To do this 
cellular fractionation studies could be performed. At each gestational time point, 
myometrial samples would be fractionated into both the nuclear and cytoplasmic 
fractions. The nuclear cell lysate would then be analyzed by SDS-PAGE and Western 
blots for the presence of Hsf1 using a Hsf1 specific antibody. This would help confirm 
the presence of Hsf1 in the nucleus of uterine myocytes. 
Hsf1 is also known to form complexes with several proteins, such as PARP-1 and 
Hsf2 which were studied in this thesis. However, a direct interaction between these 
proteins was not investigated. Therefore, co-immunoprecipitation experiments should be 
performed. Following pull-downs with Hsf1 specific antisera, gel electrophoresis and 
immunoblotting, the blots would be probed with antibodies specific to Hsf2 and PARP-1 
to confirm whether there is a direct interaction between these proteins and Hsf1. This 
could be performed in both the rat tissue samples and the hTERT-HM cell lysates to 
show if this potential interaction occurs in both rat and human tissues. Confirming or 
disproving these interactions would lead to a better understanding of the exact 
mechanisms underlying Hsf1 upregulation of target genes. 
Since Hsf1 was shown to be upregulated during the proliferation phase of 
myometrial differentiation, more studies involving this mechanism should be performed. 
Although the literature suggests that Hsf1 is most likely what induces proliferation (Dai 
et al., 2007; Santagata et al., 2011), this current study showed that Hsf1 does not appear 
to induce proliferation. However, the reverse possibility that proliferation induces Hsf1 
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expression also needs to be studied. If proliferation was induced in myometrial cells, we 
may then see a subsequent upregulation in Hsf1 expression. Perhaps certain growth 
factors could be added to hTERT-HM cells to induce proliferation. Proliferation could 
then be confirmed using an MTS assay, and if cells are experiencing increased levels of 
proliferation, then lysates could be collected for protein analysis. The lysates could then 
be subjected to immunoblot analysis using an antibody specific to Hsf1. PARP-1 could 
also be studied since it was shown to be involved in proliferation in our previous studies. 
These future experiments should help expand our knowledge of Hsf1 and its 
associated factors in the uterus, and therefore lead to a better understanding of how Hsf1 
may influence the development of the myometrium throughout pregnancy.  !
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